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ABSTRACT 
Clay, Charles Michael. M.S., Department of Chemistry, Wright State University, 2011. 
Synthesis of Isatin Derivatives Used for the Inhibition of Pro-Apoptotic Jurkat T Cells. 
 
 A range of substituted 1H-indole-2,3-diones (isatins) was synthesized to assess  their 
capability to inhibit caspases and prevent apoptosis in Jurkat T cells. The key steps in the 
synthesis of such molecules involved electrophilic substitution of the C-5 position of the isatin 
nucleus (if necessary), N-alkylation, Wolff-Kishner reduction of the C-3 carbonyl group and 
finally, Knoevenagel condensation. The design and synthesis of such potential inhibitors was 
guided by SAR studies of peptide based inhibitors such as “Q-VD-O-Ph”, as well as small-
molecule inhibitors based upon the isatins scaffold. Previously, 3-(2,6-difluorobenzylidene)-5-
nitroindolin-2-one has been shown to inhibit apoptosis in human Jurkat T cells at 5 μM activity.  
Herein, it is shown that by increasing the functionality of  such oxindole derived inhibitors from 
two points of variability (e.g., 1-(2,6-difluorobenzyl)-3-((pyridin-4-yl)methylene)indolin-2-one), 
to three points of variability by adding an electron-withdrawing group such as a chlorine atom at 
the C-5 position, the potency of the molecules against apoptosis was approximately increased up 
to 2-fold. Several other 3-substituted benzylidene derivatives were tested against human Jurkat T 
cells and were found to be active at micromolar concentrations. 
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Introduction 
 Isatin (1-H-indole-2,3-dione, Figure 1) and derivatives possess a broad range of 
biological and pharmacological properties and are widely used as starting materials for the 
synthesis of a broad range of heterocyclic compounds and as substrates for drug synthesis. 
Figure 1 
 
 
Formerly, the study of isatin derivatives was connected with dye synthesis, but more 
recently these heterocycles have been shown to demonstrate antiprotozoal, antibacterial, 
antifungal, antiviral, anti-HIV, anticonvulsant, antitumoral, anti-inflammatory, and 
antihelminthic activities; influence neurodegenerative diseases; participate in metabolism; 
acetylcholinesterase inhibitors; and stimulate the growth of plants.
1
 Drugs containing the isatin 
skeleton are used to treat diseases such as epilepsy
2
, tuberculosis
3
, and bulimia
4
. Therefore the 
need to create novel isatin derivatives for emerging drug targets is an active area of medicinal 
chemistry. 
 
Synthesis of Isatin 
 The first method reported for the synthesis of isatin was developed by Sandmeyer, 
wherein the reaction of an aniline 2 with chloral hydrate and hydroxylamine hydrochloride in 
aqueous sodium sulfate forms an isonitrosoacetanilide 3. Subsequent cyclization to the isatin 1 is 
accomplished after treating 3 with concentrated sulfuric acid.
5
 The method also applies well to 
anilines with electron-withdrawing groups, such as 2-fluoroaniline.
6
 Despite its efficiency, the 
N O
O
H
1
2
3
4
3a
5
6
7
7a
 
2 
 
Sandmeyer method is limited by: a) harsh conditions; b) fails if the isonitrosoacetanilides bear 
electron-donating groups; c) the formation of a mixture of regioisomers; and d) generally 
moderate yields. However, this latter shortcoming, can be improved under microwave 
conditions.
7
 
 
N
H
O
O
NH2
Cl3CCH(OH)2
NH2OH, HCl
Na2SO4
N
NOH
H
O
H2SO4
H2OX
X X
 
 
 An important alternative to the Sandmeyer method is the method of Stolle. In this 
approach, N-substituted anilines 4 are reacted with oxalyl chloride to form an intermediate 
chlorooxalylanilide 5 which can be cyclized in the presence of Lewis acids such as anhydrous 
aluminum chloride,
8
 BF3·Et2O,
9
 or TiCl4
10
 to form 1-aryl isatin derivatives or polycyclic isatin 
derivatives 6.  
N O
O
HN
(COCl)2
N
O
R
O
AlCl3
R Cl
R
 
 Gassman described two general methods for the synthesis of isatins involving conversion 
of substituted anilines 2 into 3-methylthiooxindoles 11, which upon subsequent oxidation give 
the corresponding substituted isatins 1. The choice of methodology is dictated by the nature of 
the electronic effects of the substituents bonded to the aromatic ring. When strong electron 
1 3 2 
4 6 5 
 
3 
 
withdrawing groups are present, the oxindole derivative can be synthesized via the N-
chloroaniline intermediate 7 obtained by treating the aniline with tert-butyl hypochlorite at low 
temperatures. The resulting N-halo species, further reacts with a methylthioacetate ester to give 
the azasulfonium salts 8.
11,12
  Treatment of 8 with base generates the ylides 9 which undergo a 
Sommelet-Hauser rearrangement to give 10 after rearomatization of the intermediate 
cyclohexadienone imines. Treatment of 10 with dilute acid rapidly gives the 3-methylthio-2-
oxindole intermediates 11. The chlorination of 11 is then accomplished by treating the 3-
methylthio-2-oxindole with N-chlorosuccinimide (NCS) to give the 3-chloro derivatives 12, 
which upon refluxing in aqueous tetrahydrofuran provide the desired isatins 1. In the case of 
electron-donating groups that tend to destabilize the N-chloro intermediates (leading to 
diminished yields of the azasulfonium salt), an alternate method employs the reaction of a 
chlorosulfonium salt (formed by treating the methylthioacetate ester with chlorine), with an 
appropriate aniline to provide better yields of 3-methylthio-2-oxindoles.
11
  
 
4 
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1) tBuOCl 2) CH3SCH2CO2C2H5
3) Et3N
X
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X
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X
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 However, the Sandmeyer, Stolle, and Gassman methodologies shown above, all suffer 
from a lack of regioselectivity, especially in the case of meta-substituted anilines, wherein a 
mixture of 4- and 6- substituted isatins are observed. More recently, a new method for the 
synthesis of isatins was developed by Hewawasam and Meanwell which is insensitive to the 
electronic nature of substituents bound to the aromatic ring and is characterized by predictable 
regiochemical control.
13
 Since amino-protecting groups can direct metalation to the ortho-
position of anilines, N-pivaloylanilines and N-(tert-butoxycarbonyl)anilines 13 were used to 
generate dianions 14 using an excess of a variety of butyllithium reagents (e.g., n-BuLi, s-BuLi, 
t-BuLi) in THF at -78ºC. The resulting dianions 14 were then treated with ethyl oxalate and the 
isatins 1 were obtained after deprotection and cyclisation of the intermediate α-ketoesters 15 
1 12 11 
10 9 
7 8 
2 
 
5 
 
using HCl.
13
 This method has the advantage of being regioselective for the synthesis of 4-
substituted isatins from meta-substituted anilines where the substituent is a metalation directing 
group such as an amino protected group. 
N
H
O
O
NHCOR
BuLi (CO2Et)2
X
R = OtBu, tBu
X
NCOR
Li
Li
X
NHCOR
O
CO2Et
H3O
+
X
 
Smith at the University of Wales Swansea, used a metal-halogen exchange method for 
the synthesis of isatins and substituted isatins by lithiation of ortho-bromophenylureas, 
carbonylation and subsequent intramolecular cyclisation to give the desired products. The N‟-2-
(bromophenyl)-N,N-dimethylurea 16 underwent lithiation on the nitrogen to form a monolithio 
intermediate using MeLi, followed by bromine-lithium exchange using t-BuLi to give the dilithio 
species 17.
14
 The intermediate 17 was then exposed to carbon monoxide to give 18, which after 
cyclization forms the intermediate 19, followed by loss of LiNMe2 to give 20, and finally after 
work up with dilute acid yielded the isatin product 
1.
1 
15 13 14 
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 A rather versatile and novel two step synthesis of isatins was presented by Mironov in 
2001 and allowed for the preparation of isatins containing electron withdrawing groups such as -
CF3, -NO2, and -Cl. The method is based on the reaction between aromatic isocyanides and 
tertiary amines,
15
 where in the first step, 2-triethylammonio-3-arylaminoindolates 23 were 
obtained from the corresponding aromatic formamides 21 without isolation of the intermediate 
isocyanides 22.
16
  Heating the 2-triethylammonio-3-arylaminoindolates 23 in excess thionyl 
chloride followed by hydrolysis led to the target isatins 24.
16
 
16 
20 19 
17 
1 
18 
 
7 
 
N
H
O
O
R3
POCl3
SOCl2
R2
R1 N
H
C
O
H NEt3
R3
R2
R1 N C
KOH
R3
R2
R1
N
HN
NEt3
R1
R2
R3
H2O, H
+
a: R1 = R3 = H, R2 = NO2
b: R1 = R3 = CF3, R2 = H
c: R1 = CF3, R2 = Cl, R3 = H
d: R1 = R2 = R3 = Cl
R1
R2
R3
 
Another route to isatins which also employs N-substituted formanilides was developed by 
O. Meth-Cohn and S. Goon and involves deprotonation of a Vilsmeier reagent or substituted 
chloroiminium ion, followed by dimerisation of the carbene formed upon treatment with base, 
and finally electrophilic cyclisation of the dimer by bromonium ion action.
17
 This route to isatins 
is said to be general for various ring substituents including electron-withdrawing groups such as 
the nitro group. Formation of isatin in a one pot synthesis takes place by reacting the N-
substituted formanilides 25 with oxalyl chloride in THF to give the Vilsmeier reagent 26, 
followed by treatment with Hünig‟s base to form a nucleophilic carbene 27. The unstable 
arylamino-dimers 28 have a limited shelf-life and react with electrophiles such as bromine to 
give intermediates such as 29, which upon cyclisation to 30, and hydrolysis yield the desire 
isatins 31. 
22a-d 
24a-d 
21a-d 23a-d 
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Electrophilic Aromatic Substitution of Isatin 
Nitration of Isatin 
In 1925, Calvery reported the nitration of isatin at the C-5 position using fuming nitric acid in 
concentrated sulfuric acid.
18
 However, a more convenient method to synthesize 5-nitroisatin (33) 
involves the dropwise addition of a solution of isatin (32) in sulfuric acid to a solution of 
potassium nitrate dissolved in concentrated sulfuric acid at 0-4ºC. The isatin so obtained was 
isolated, as bright yellow/orange crystals with a melting point of 252-254 ºC.
19
 
29 30 
28 27 
27 26 25 
31 
 
9 
 
N O
O
H
N O
H
1. H2SO4, KNO3
2. H2SO4, H2O
Temp: 0-4ºC
O2N
O
 
 
Halogenation of Isatin 
The chlorination of isatin at the C-5 position has been described using N-chloroamides, N-
chloroimides and also using N-chlorosaccharins in a heterogenous medium (SiO2/CH2Cl2).
20
  
Furthermore G. F. Mendoca reported using the relatively stable reagent trichloroisocyanuric acid 
(TICA) (34), as an efficient new source of electrophilic chlorine and this provides a relatively 
inexpensive route to the chlorination of isatins (32).
21
 Using this protocol, the 5-chloroisatin (35) 
was isolated in 72% yield in less than 5 minutes and no N-chlorination of isatin or frequently 
formed isomeric 7-chloroisatin were detected in the crude reaction product by HRGC (high-
resolution gas chromatography). It is believed that the strongly acid medium promotes the 
formation of a superelectrophilic species wherein TICA being either polyprotonated or 
protosolvated causes the “Cl
+
” transfer to isatin more efficiently due to the charge-charge 
repulsion relief. 
N O
O
H2SO4
rt, 5 min.
+ N
N
N
O
OO
ClCl
Cl
N O
O
H H
Cl
 
32 35 34 
32 33 
 
10 
 
 
 Mono-halogenation (-Cl, -I, -Br) of isatin (32) can be achieved by reacting N-
halosaccharins 36 with isatin in the presence of SiO2 at r.t to specifically produce the 5-halo 
derivatives 37 as reported by de Silva and de Mattos.
20
 This method is an alternative to the use of 
highly toxic and corrosive Cl2 and Br2, which can lead to other products such as 5,7-dibromo-
3,3-dialkoxyoxindole when the bromination of isatin is attempted in alcoholic media.
22
 
N O
O
SiO2
CH2Cl2, rt.
+
N O
O
H H
X
S
N
O
O O
X
X = Cl, Br, I
 
N-Alkylation of Isatin 
 Various methods have been used for the preparation of N-alkylated isatins which can be 
successfully achieved under basic conditions using alkyl chlorides, bromides, and iodides; as 
well as reactive allyl-, benzyl-, and propargyl halides. Conventional heating is often employed to 
produce the N-alkylated isatins from temperatures of from 40-100ºC under reflux. In general, the 
N-alkylation of isatin proceeds by reacting the isatin (32) substrate with any variety of base and 
solvent combination shown in Table 1, to generate the salt of the isatin 38 which subsequently 
37 32 
36 
 
11 
 
reacts with an alkyl halide to produce an N-alkylated isatin 6. 
N O
O
RX
N O
O
H R
base
N O
O
 
  
Table 1: Reported Solvents and Bases used for the N-alkylation of 
Isatin
28,29,35,38,39
 
Base Solvent 
Na2CO3, K2CO3, Cs2CO3, LiH, 
NaH, CaH2, TEA, LiOH, NMM, 
NaOEt, 
DMF, DMA, HMPT, MeCN, 
DMSO, NMP, EtOH, MeOH, 
Me2CO 
 
Very few 7-substituted derivatives have been reported, however a method for the N-alkylation of 
isatins introduced by Garden involves the use of calcium hydride as base in N,N-
dimethylformamide (DMF) at 40-50ºC  for the substituted isatin 39 to produce the 7-substituted-
N-alkylisatins 40 that have electron withdrawing groups bonded to the aromatic nucleus. The 
isatin derivatives with electron-withdrawing groups bonded to the aromatic nucleus, at the C-5 
and C-7 positions, reacted more readily with CaH2 at room temperature than did isatin, revealing 
the increased acidity of the amide proton. The use of CaH2 is beneficial because of the ease with 
32 6 
38 
 
12 
 
which it can be handled and exposed to the atmosphere, especially in humid climates, in 
comparison to NaH.
23
  
N O
O
N O
O
H R
DMF, CaH2
Z
Y Y
Z
RX
 
Sodium hydride is a very strong base which is most often used to perform the N-alkylation of 
isatins using alkyl halides.
24,25,26,27
 Additionally, it has been reported that the direct alkylation of 
isatin (32) by halomethyl ketones was achieved using sodium hydride or lithium hydride in 
anhydrous DMF at temperatures of from -15ºC to ambient conditions to form the N-
acetonylisatins (R= Me) or N-phenacylisatins (R= Ph) 41.
28
 
 
N O
O
N O
O
H
RCOCH2I
O
R
NaH or LiH, DMF
 
Although conventional heating is used to generate N-alkylated products on a large scale, it also 
presents some drawbacks including: the general base lability of the isatin nucleus; the use of 
hazardous reagents such as metal hydrides requiring anhydrous solvents; the use of high boiling 
aprotic organic solvents leading to complex workups; the use of carcinogenic solvents in some 
cases, and side reactions due to the presence of keto-carbonyls (i.e., reductions when metallic 
39 40 
32 41 
 
13 
 
hydrides are used, aldolisation when K2CO3 in acetone is employed).
29
 In addition some 
conventional reactions can be lengthy, involving reaction times of hours or days with 
consequential formation of unwanted by-products. Thus, microwave (MW) irradiation has 
gained popularity in the last few decades as an alternative energy source, and it is especially 
utilized because it accelerates a wide variety of reactions and minimizes thermal decomposition 
of the products. Several reviews on the advantages of applying MW irradiation to organic 
synthesis have been published which involve multi-component reactions,
30
 classic organic 
reactions,
31
 and green organic synthesis.
32
 More recently, the microwave promoted N-alkylation 
of isatins was done using various reaction conditions, however the best results were obtained 
using K2CO3 or Cs2CO3 and a few drops of DMF or N-methyl-2-pyrrolidinone (NMP).
29 
 The use KI as a catalyst for the N-alkylation of isatins was first reported by Torres
33
 
followed by Vine.
34
 In a study describing the first positive allosteric modulators of muscarinic 
acetylcholine receptor subtype 5, Lindsey
35
 developed a parallel microwave procedure for the 
preparation of a variety of N-benzyl isatins 43 from substituted isatins 1 and a variety of benzyl 
halides 42 (2.5 equiv.) by employing K2CO3 (2.0 equiv.) and KI (0.1 equiv.) as a catalyst in 
acetonitrile (ACN) (3 mL). Next, the reactions were partitioned into CH2Cl2 and H2O and then 
passed through disposable phase separator columns (Biotage Isolute) after which the organics 
were concentrated on a heated air-drying block and then analyzed by 
LCMS.
 
14 
 
N O
O
N O
O
H
+R1
R2
X
R1
R2
K2CO3, KI, ACN
MW 160ºC, 10 min.
  
Interestingly, Torisawa found that attempts at reducing 5-nitro isatin (33) by Red-Al (5 
equiv) or NaBH4 provided ring-opened products 44 and 45.
36
 Given the susceptibility of 5-
nitroisatin to undergo nucleophilic cleavage of the N1-CO bond under basic conditions, a novel 
modified protocol was developed for N-alkylation of such derivatives employing a mild base 
combination of CuCO3/Cs2CO3 (1:2) in anhydrous DMF to afford 46.
 
This reagent combination 
showed increased nucleophilicity at nitrogen by the complexation between Cu and amide 
nitrogen.
36
 
N O
O
H
1. 0.5-1 eq NaBH4, MeOH
from 1 to 5ºC, 20-30%
O2N
O2N
NH2
OMe
O
O
1. 5 eq Red-Al, toluene
from 20 to 80ºC, 35%
O2N
NH2
OMe
N O
1. CuCO3-Cs2CO3, DMF, rt
50-70ºC, 1hr 90%
O2N
Cl
Br
2.
O
Cl
                                         
1 43 
44 
45 
46 
33 
42 
 
15 
 
 The N-carboxymethylation of isatin was performed under basic conditions (1.5 equiv. of 
K2CO3 in DMF), allowing the formation of the conjugate base of isatin followed by alkylation 
(48h) at room temperature using ethyl bromoacetate 47 (1.5 equiv.) and tetrabutylammonium 
bromide (TBAB, 0.1 equiv) as the phase transfer catalyst. The ester function of 48 was 
saponified to the corresponding carboxylic acid 49 using sodium hydroxide (2 equiv.) for 4 h at 
room temperature in ethanol/water (1/1) followed by neutralization with aqueous HCl. The 
amides 50 were then prepared by treatment with ethyl chloroformate (1.2 equiv) and 
triethylamine (2 equiv.) for 30 min. at -10ºC followed by reaction with the desired amines (2 
equiv.) for 2h.
37
 
N O
O
1) NaOH, EtOH
H
+
K2CO3, DMF
TBAB, 48h, rt
R
2) HCl, H2O
Br
O
OEt
N O
OR
CO2Et
N O
OR
CO2H
1) Et3N, ClCO2Et, CH2Cl2
2) HNR1R2 N O
OR
N
R1
R2
O
 Other novel N-alkylation reactions involve the formation of 1-alkylisatins via aldol-retro-
aldol condensation reaction. Thus, 5-substituted isatin 1 was refluxed in acetone with alkyl 
halides in the presence of anhydrous potassium carbonate to give N-alkylated aldol product 51. 
The N-alkylated aldol product was then heated in o-dichlorobenzene at 160-165ºC for 
dealdolisation to occur, giving the 1-alkylated isatins 52.
38
 Thus, this methodology was 
developed primarily for employing N-alkylation reactions using acetone as the solvent and 
49 50 
47 48 1 
 
16 
 
anhydrous potassium carbonate which consequently forms the undesired aldol product 51, which 
can be converted to the isatin derivative by the dealdolisation procedure. 
N O
O
o-Cl2C6H4
N O
H R'
K2CO3, R'-X
Me2CO
R R
OH
heat N O
O
R'
R
O
 
 Di Carlo and Lindwall showed the N-alkylation of isatin via a “Michael addition” 
involving the reaction of acrylonitrile with isatin (32) in ethanol, in the presence of a catalytic 
amount of trimethylbenzylammonium hydroxide to give 1-cyanoethylisatin (53).
39
 
N O
O
N O
H
CH2=CHCN
Triton B, EtOH
O
CN  
 One of the more novel bases for N-alkylation reactions is the solid supported reagent 
potassium fluoride on alumina (KF/Al2O3).
40
  KF/Al2O3 was originally introduced in 1979 by 
Ando et al.
41
 as a useful agent for inducing alkylation reactions in general. It possesses 
advantages for both solution phase and solid phase chemistry and the excess support bound 
reagent can be removed by filtration, avoiding tedious work-ups. The strong basic nature of 
KF/Al2O3 has allowed it to replace organic bases in a number of reactions including selective N-
1 51 
52 
32 53 
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alkylation of amides,
42
 epoxidations,
43
 diazetizations,
44
 Sonogashira couplings,
45
 Suzuki 
couplings,
46
 Knoevenagel reaction,
47
 and Horner-Emmons chemistry.
48
 Furthermore, Ando et al. 
have argued that KF/Al2O3 derives its basicity from the presence of three basic species thought 
to be present in KF/Al2O3: (1) the presence of active fluoride, (2) the presence of [Al-O
-
] ion 
which generates OH
-
 when water is added, and (3) the cooperation of F
-
 and [Al-OH].
38
  
Chiyanzu  reported using the KF/Al2O3 to perform high throughput parallel solution phase 
synthesis of N-alkylated isatins 40 in acetonitrile starting from the substituted isatin 39.
40
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Biological Background 
 Caspases or cysteine aspartyl-specific proteases have been known to play a key role in 
apoptosis, or programmed cell death.
49
 Apoptosis, is a highly conserved process which is an 
energy-dependent and genetically controlled mechanism of cell disposal characterized by lack of 
inflammatory response that serves to maintain homeostasis in multi-cellular organisms.  
Dysregulated apoptosis is believed to play a role in various serious pathological conditions such 
as cancer or autoimmune disorders or even ischemic injury and some neurodegenerative 
disorders, such as Alzheimer‟s, Parkinson‟s, and Huntington‟s diseases.
25
 The caspsase family of 
cysteine proteases can be subdivided into three groups; where caspases-1, -4, -5, and -13 are 
involved in inflammation; caspases-6, -8, and -10 are initiator caspases found at the top of the 
39 40 
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signaling cascade; and caspases-2, -3, and -7 are effector caspases which are activated further 
downstream.
50
  The effector or executioner caspases are responsible for the physiological 
changes (e.g., cleavage of the DNA repair enzyme poly(ADP-ribose) polymerase-1) and 
morphological changes (e.g., nuclear membrane damage and membrane blebbing, which is an 
irregular bulge in the plasma membrane) that occur in apoptosis.  
 Caspase cleavage of peptide targets is based on nucleophilic cysteine residues located 
within the caspase which attack the carbonyl group of an aspartic acid residue within a specific 
tetrapeptide sequence (e.g., ~P4-P3-P2-P1~) of a large peptide molecule.
51
 The standard 
nomenclature for protease substrate cleavage, Pn, P3, P2, P1, P1‟, P2‟, P3‟, Pn‟, etc designates 
amino acid side chains of a peptide substrate, whereas, the corresponding bonding sites in the 
protease active site are designated as the Sn, S3, S2, S1, S1‟, S2‟, S3‟, Sn‟, etc. subsites.
52
 Caspases 
have a near absolute requirement for aspartic acid (P1) in the S1 subsite of the enzyme, such that 
substitution for another amino acid results in >100 fold reduction in catalytic efficiency.
50
 
Cleavage at the aspartic acid residue occurs by hydrolysis of the amide bond between the P1 
residue and the adjacent “C-terminal” amino acid residue. 
 When designing peptide based caspase inhibitors, the inhibitor is comprised of a peptide 
sequence (up to a tetrapeptide) possessing an electrophilic functionality (termed the “warhead”) 
at the C-terminus of the peptide which may function as a reversible (e.g., ketones, aldehydes, and 
nitriles) or irreversible (e.g., acyloxymethylketones and halomethylketones) moiety in order to 
react with the sulfur atom of cysteine.
50
 In addition, the P4 amino acid can be capped with a non-
specific neutral group such as an acyl moiety (i.e., Ac-P4-P3-P2-P1-W, where “Ac” is an acyl 
group and “W” is a „warhead‟). In previous years, several peptide based caspase inhibitors such 
as Z-VAD-fmk
53
 and Boc-D-fmk were found to prevent apoptosis,
54
 unfortunately when used at 
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high doses these inhibitors appear to have non-specific effects and/or become cytotoxic.  
Moreover, their size and polarity render them inadequate to pass through the blood brain barrier 
(BBB) for uses in diseases affecting the central nervous system. More recently, the broad-
spectrum apoptosis inhibitor, quinolyl-valyl-O-methylaspartyl-[2,6-difluorophenoxy]-methyl 
ketone Q-VD-OPh,
55
 (seen in Figure 2) has been shown to prevent all major apoptotic pathways, 
be non-toxic even at high concentrations, and be capable of crossing the blood brain barrier. Q-
VD-OPh has proven to inhibit apoptosis at concentrations as low as 5 μM against human Jurkat 
T lymphoma cells.
56
 Although useful tools in vitro, there are several drawbacks of peptide-based 
inhibitors as potential drugs such as indiscriminate competing reactions in vivo with other 
nucleophiles, rapid physiological clearing times, and poor metabolic stability. 
Figure 2 
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Small Molecule Approach 
The limitations of peptide based caspase inhibitors led SmithKline Beecham to conduct a high-
throughput screening of their compound library for small-molecule inhibitors against caspase-3.  
This investigation led to the identification of the 5-nitroisatins below which possessed IC50‟s of 3 
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μM (33), 1 μM (54), and 0.25 μM (55) respectively.
57
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The importance of an electron-withdrawing group at the C-5 position was established by 
screening several 5-substituted isatins and observing a correlation between the electron-
withdrawing ability and effectiveness of the molecules to inhibit caspase-3.
57
 Their results 
suggested that the electrophilicity of the isatin carbonyl was important for activity, even though 
none of the electron-withdrawing substituents are in resonance with the C-3 carbonyl. The 
critical electron-withdrawing effects are presumably attributable to simple inductance of electron 
density from the aromatic nucleus of the isatin core to the nitro-group. In addition, the 
SmithKline Beecham group provided binding models based on X-ray structures demonstrating 
the formation of a tetrahedral intermediate between the cysteine thiol of caspase-3 and the isatin 
carbonyl group. It was found that the positioning of the inhibitor suggested that access to the 
extended binding regions of the active site (S2-S4) could possibly be attainable by extending 
groups off the C-5 position of isatin.
57
 Thus, a sulfonamide group was introduced as the 
replacement for the nitro group at C-5 position due to the fact that the nitro group is susceptible 
to metabolic reduction. Furthermore, the sulfonamide retains the desired electronic properties, is 
metabolically stable, and allows for the incorporation of molecular diversity.
58
 
55 33 54 
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The first attempt at the chlorosulphonation of isatin involved the addition of 
chlorosulphonic acid in an ice bath followed by heating at 70 °C done by Somasekhara et al.
59
  
This procedure was reported to afford the desired derivative 60 as a yellow powder which was 
recrystallized from acetone-benzene and had a melting point of 150-152 °C. SmithKline 
Beecham‟s first attempt at preparing the desired 5-N,N-dialkylisatin sulfonamides was done 
initially by following the Somasekhara method in hopes of securing the 5-chlorosulfonylisatin as 
an intermediate. Thus, the SmithKline Beecham group found that upon heating isatin (32) in 
chlorosulfonic acid, they actually formed the gem-dichloro derivative 56. In any event, the 5-
isatin sulfonamide was ultimately obtained by reaction of the resulting gem-dichloro species 56 
with an amine to give 57, followed by hydrolysis to yield 58. Later, SmithKline Beecham 
recognized that the confusion arose from the fact that Somasekhar‟s combustion analysis results 
for the suspected sufonyl chloride 60 were erroneous based on the fact that their characterization 
relied on only N and Cl analysis (N = 5.0, Cl = 24.70),
59
 for which the gem-dichloro derivative 
prepared by SmithKline Beecham also fits the combustion analysis data reported by 
Somasekhara.  
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Lee et al. also showed that a more straightforward route to obtaining the 5-N,N-dialkylisatin 
sulfonamides 61 involved the preparation of 5-chlorosulfonylisatin 60 by treating the then 
commercially available sodium 5-isatin sulfonate 59 with phosphorus oxychloride in 
tetramethylene sulfolane at 80ºC.
60
 In addition, the melting point of the 5-chlorosulfonylisatin 
(188-190ºC)
26
 varies greatly compared to the mp reported by Somasekhara. 
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Evaluation of a series of amine inputs led to the identification of isatin sulfonamide 62, 
which retained significant activity against caspase-3 (Ki(app) = 1.4 μM), compared to the lead 33 
(Ki(app) = 0.5 μM), and furthermore, the isatin sulfonamide 62 possessed much improved 
selectivity for caspases-1, 3, and 7.
58
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 The extension of groups off the pyrrolidine ring of the sulfonamides led to the 
identification of isatin sulfonamides 63 and 64 with activities of 60 and 15 nM (Ki(app)) 
respectively as inhibitors of caspase-3. It was found that these inhibitors exhibited 100-fold or 
greater selectivity for caspase-3 and 7 versus all other family members with the exception of 
caspase-9 showing selectivity from 10- to 50 fold.
57
 Lee et al. believe that the observed 
selectivity for the isatin sulfonamides was likely due to three hydrophobic residues in the S2 
pocket (Tyr
204
, Trp
206
, and Phe
256
) that are unique to caspase-3 and 7, by examining protein 
residues proximal to the catalytic cysteine active site. A 2.8-Å resolution X-ray co-crystal 
structure of caspase-3 and the inhibitor 64 was obtained and reveals that the S2 pocket is 
involved in extensive hydrophobic contacts with the pyrrolidine ring, conferring specificity to 
the isatin sulfonamides.
58
 As mentioned previously, the S1 subsite of caspases confers critical 
selectivity for cleavage of substrates possessing a P1 aspartic acid residue in peptide based 
inhibitors, however, in the co-crystal structure shown by Lee et. al. the S1 subsite is occupied 
only by a water molecule.
58
 Thus, previous inhibitor studies suggested the S1, S3, and S4 subsites 
are critical for potent and selective inhibition of caspases, given the S1 subsite confers selectivity 
for caspase, while the S3 and S4 subsites are believed to be critical for selectivity amongst 
caspases. However, using the sulfonamide co-crystal structure model it was shown that caspase-3 
exhibits minimal interactions with the S3 and S4 subsites and selectivity is obtained by way of 
hydrophobic contacts between the pyrrolidine ring of the inhibitor and residues of the S2 
hydrophobic pocket. It is also speculated that possible elaboration with chemical groups which 
can bind in the extended binding sites (S3 and S4) where caspase-3 and 7 diverge may enhance 
selectivity and affinity for one caspase over the other.
57
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 The importance of ring size of the isatin sulfonamides on activity was investigated and 
evaluated for compounds 62 and 65-67. In general, there was no great effect on activity based on 
the ring size from five to seven carbons, yet the azetidine ring for 65 resulted in a 10-fold 
increase of potency compared to the pyrrolidine moiety 62. Nonetheless, structural activity 
relationships (SAR) were thus further pursued using the pyrrolidine derivatives due to the 
commercial availability of substituted pyrrolidines.
57
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Using compound 62 and extending groups from the C-2 position of the pyrrolidine led to another 
pivotal discovery involving the importance of chirality of the extended functionalities. Using 
both R and S configurations of the methoxymethyl groups for 63 and 68, the (S)-configuration 
was found to be significantly more active providing >100 fold activity over the R-
stereochemistry.
57  
65 62 
66 67 
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 Furthermore the SmithKline Beecham group increased the potency of their compounds 
by 2-3-fold by replacing the methoxymethyl group attached to the pyrrolidine ring of 63 with a 
more hydrophobic moiety such as a phenoxy group, as seen in 69.
57
 The same strategy used to 
increase the potency of their 5-nitroisatins by way of N-alkylation was then applied to the isatin 
sulfonamide compounds. Similarly, a direct correlation was noticed when alkylating with larger 
hydrophobic groups attached to the nitrogen and an increase in potency was displayed by 70 over 
its N-H analog 69. 
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IC50  44 nM IC50  2.5 nM
 
 W. Chu et al. at the Washington University School of Medicine further applied the use of 
the potent isatin sulfonamides derived by the SmithKline Beecham corporation and suggested 
another mechanistic mode of attack of the isatin sulfonamide scaffold by introducing an isatin 
Michael acceptor (IMA) such as a vinyl dicyano group at the C-3 position. The Michael addition 
63 (S)-configuration 68 (R)-configuration 
69 70 
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reaction generally occurs by the cysteine thiol “soft” nucleophile attacking an α,β-unsaturated 
carbonyl compound.  By condensing the isatin sulfonamide 71 with malononitrile in methanol, 
the IMA analog 72 showed an increased potency of roughly 10-fold for caspase-6 when 
compared to its complementary precursors, while still retaining the high selectivity for caspases-
3/7 as well, as a reversible inhibitor.
61
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 In order to find caspase 6 inhibitors, Chu et al. sought to replace the 
phenoxymethylpyrrolidine ring in 72 with other nitrogen heterocycles to create the 
thiomorpholine analogue 74  by condensing 73 with malononitrile in methanol, which further 
exhibited a reduction in selectivity for caspase-3 and increased caspase-6 selectivity by 85-fold.
62
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Other Applications of Isatin Sulfonamides 
 More recently, isatin sulfonamides have been utilized extensively as biomarkers for 
noninvasive positron emission tomography (PET) imaging of apoptosis in vivo which can permit 
the detection of tumor biological changes.
63
 This process is initiated by labeling the isatin group 
with an 
18
F radio isotope using novel “click” reactions. Given that the half-life of the radiotracer 
is t1/2 = 110 minutes, the 
18
F labeled isatin sulfonamide can be administered to a living organism 
using PET imaging which allows for high resolution quantitative imaging of biochemical 
processes by detecting the distribution pattern of the biomarker over time. The development of a 
noninvasive imaging procedure that can study the process of apoptosis in a variety of disease 
states and monitor the ability of a drug or other treatment is a great value to the on-going 
research for drug discovery and the community. 
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Results and Discussion 
WSU Approach  
The goal of this project was to design and synthesize potential cell death inhibitors based 
on the isatin scaffold while incorporating structural features gleaned from previous SAR studies 
of peptide based as well as small molecule inhibitors. To this end, both isatins and oxindoles 
were used as starting materials and further modified to ultimately synthesize a series of 
benzylidene oxindole derivatives which provide three points of variability, and function as 
caspase inhibitors likely via a Michael type addition reaction. This strategy also employed the 
“libraries from libraries”
64
 concept using a “toolbox” of various chemical transformations to 
complete a library of isatin and oxindole derivatives to assess biological properties and make use 
of such information in the design of more potent inhibitors. The idea of employing three points 
of variability is a novel concept given that the SmithKline Beecham lead (e.g., the 5-nitroisatins), 
possessed only two points of variability at the C-5 and N-1 positions. The group at Washington 
University St. Louis developed their lead isatin sulfonamide molecules using just two points of 
variability, eventually incorporating the vinyl dicyano group at the C-3 position which displayed 
selectivity for caspase-6 over caspase-3, however such derivatives still allow for only two points 
of diversity. The WSU approach entails the generation of a library of oxindole molecules derived 
from isatins which takes advantage of the potential for exchangeable chemical transformation at 
the C-3 position of the oxindole substrate shown in Figure 3.  
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Figure 3 
N O
O
R2
R1
N O
R2
R1
CN
CN
N O
R2
R1
R3
SmithKline Beecham Washington Univ. St. Louis Wright State Univ.
 
 Given that Q-VD-O-Ph proved to inhibit apoptosis against Jurkat T cells at micromolar 
concentrations, it was deemed important to employ some of the functionalities of this peptide 
inhibitor to the design of our isatin library. One of the main points of interest was the 2,6-
difluorophenoxy “warhead”, which is believed to play an important role as an electrophilic 
moiety that may act as a stable leaving group post cysteine nucleophilic attack. In addition Hagar 
Abdallah found that 5-nitrooxindole bearing a 2‟6‟-difluoro moiety at C-3 (i.e., 75) was also 
active, matching the 5 μM activity seen by Q-VD-OPh.
55
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Further investigations showed that the 2,6 difluorophenyl moiety on the oxindole scaffold 
alone was not active (i.e., 76), and the electron withdrawing properties of the nitro group at the 
C-5 position, similar to SmithKline Beecham molecule 33, were critical for  biological activity. 
Thus, it was deemed important to introduce an electron withdrawing group at the C-5 position. 
Therefore, one of the goals of this project was to design molecules which incorporate non-
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reducible electron withdrawing groups in place of the nitro and sulfonamide groups employed 
previously, and to that end the chlorine atom was chosen, given its metabolic stability. 
In addition, various substitution patterns were examined on the benzylidene moiety also 
based upon previous findings. For instance, the para-methoxy benzylidene group in particular 
was found by H. Abdallah to inhibit apoptosis against Jurkat T cells in vitro at approximately 50 
μM, in contrast to the former preconception that a strong electron-withdrawing group was 
necessary to promote nucleophilic attack at the beta-carbon of the α,β-unsaturated amide moiety. 
This finding suggested that there was a role played by the lone pair electrons on a group attached 
to the benzylidene group, possibly exerting its effect by way of hydrogen bonding (vide infra, 
77). This latter rationalization is supported by the research of Loser et al. who propose that the 
hydrogen binding between the inhibitor and the caspase greatly influences the inhibition 
capabilities of the inhibitor. Accordingly, substituent groups with available electrons such as 
hydroxy and methoxy groups could be used as effective groups to inhibit caspases.
65
 Adding 
support to this hypothesis was the finding that an oxindole bearing a 4-pyridyl substituent (e.g., 
compound 78) was found to inhibit apoptosis in Jurkat T cells at 50 μM, similar to the methoxy 
moiety, given that pyridine nitrogen also possesses a pair of electrons which is capable of 
hydrogen bonding.  
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Following up on that finding and described herein (vide infra), a para-methoxy 
benzylidene oxindole analogue was prepared and was N-alkylated with the 2,6-difluorobenzyl 
moiety in hopes of increasing the potency of the previous lead. In addition, several pyridine 
benzylidene derivatives were prepared and tested based on the fact that they possess lone pairs of 
electrons, as does the methoxy functional group. 
Thus, the starting point for this work involved the fact that the 5-nitro-2,6-difluoro analog 
75, the para-methoxy derivative 77, and 4-pyridyl substituted 78 benzylidene compounds were 
tested previously by H. Abdallah and found to be active against Jurkat T cells. It was envisioned 
that by incorporating a non-reducible, electron-withdrawing functionality at the C-5 position, 
along with groups on the benzylidene moiety capable of accepting hydrogen bonds would likely 
lead to positive results. Moreover, given that previously only N-unsubstituted benzylidene 
compounds were tested against Jurkat T cells by H. Abdallah, it was deemed important to 
perform the N-alkylation of these active compounds by analogy to the improvement in caspase 
inhibition found by N-alkylation of isatin sulfonamides described earlier. In addition to the 
synthesis of the desired benzylidene oxindole compounds mentioned, a small library of N-
N
O
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alkylated isatins was created along with their 5-chloro derivatives as possible caspase inhibitors 
which might be biologically tested if time permitted. 
The N-alkylations of the isatins were conducted using a range of alkylating groups 
including hydrophobic, disubstituted and unsubstituted benzylic groups based upon the findings 
by SmithKline Beecham which showed that the N-alkylated hydrophobic modifications possibly 
extend to the hydrophobic S2-S4 regions of a caspase enzyme, and significantly increase 
inhibition for caspases 3/7.
56
 Based upon these findings, isatin was N-alkylated with a simple 
benzyl group which would provide the relevant hydrophobic characteristics and allow possible 
access to the S2-S4 subsites of an enzyme. Also, a 2,6-difluorobenzyl group was added onto the 
nitrogen atom since this particular substitution was thought to play a key role in the inhibitory 
effects demonstrated by the Q-VD-OPh molecule and the Abdallah compound 75. As an 
alternative to the 2,6-difluoro moiety, a 2,6-dichloro analog was also created. Furthermore, two 
specific outlier N-alkylations were performed, one by way of a nucleophilic substitution reaction 
to make a carboxy ester using ethyl bromoacetate and the other by way of Michael addition at 
the isatin nitrogen to make a tert-butyl carboxy ester using tert-butyl acrylate. The carboxy ester 
moieties could potentially be hydrolyzed into carboxylic acid groups and were chosen due to this 
potential and consequential resemblance to an aspartic acid and glutamic acid residue, 
respectively. In the event, the tert-butyl group, in which the carbon backbone extended from the 
isatin nitrogen is one carbon longer than the carboxy ester moiety obtained using ethyl 
bromoacetate, was indeed spontaneously hydrolyzed into a carboxylic acid group and not only 
resembles a glutamic acid residue in a peptoid sense but also acts as a hydrophilic moiety. While 
such a hydrophilic group was not found effective in the corresponding isatin sulfonamides, it is 
possible that such an analogue could serve as an antagonist to the known inhibitory effects 
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created when using hydrophobic groups off the isatin nitrogen. Moreover, it was envisioned that 
these substrates could be further modified to add an amide group at the carboxylic acid end, 
allowing another point of variability. 
In summary, in order to synthesize a compound that might have potential to inhibit 
caspases in vivo, it appeared ideal to incorporate electron withdrawing groups at the C-5 
position; extend groups from the C-3 position that may act as “Michael acceptors” such as a 
benzylidene moiety or that may hydrogen bond, and finally extend possible hydrophobic groups 
off the nitrogen atom of the isatin scaffold to access the S2-S4 subsites of the targeted enzyme. 
Thus, Figure 4 below shows one route to achieve the desired tri-substituted isatin targets. 
Figure 4  
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Figure 4 shows a retro-synthetic analysis in which an N-alkylated benzylidene oxindole 
is seen as arising from N-alkylation of the C-3 substituted oxindole in a final step. The 
benzylidene oxindole, in turn, is visualized as arising from the aldol condensation of an oxindole.  
The oxindole can then be seen as arising from a Wolff-Kishner reduction on a 5-substitued isatin. 
However, it can be demonstrated that the desired end product can also be achieved by 
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performing the N-alkylation as the first step as opposed to the last step, followed by the Wolff-
Kishner reduction and condensation reaction as shown in Figure 5 below. 
Figure 5 
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N-Alkylation of Isatin via Microwave Irradiation 
The first phase of this project involved an examination of the N-alkylation of isatins using 
the solid base KF/alumina and was initially carried out using the CEM Discover microwave so as 
to rapidly probe the optimal parameters before upscaling the process by means of conventional 
heating. Microwaves heat an organic reaction sample more evenly (since heating is generated 
from within the sample) than the conventional heating mantle or immersion bath where the walls 
of the vessels are warmer than the cores causing hot spots which might trigger the formation of 
side-products.
66
 The use of microwave accelerated synthesis is also beneficial in that it allows for 
homogeneous heating which causes the reaction temperatures to rise quickly (up to 10˚C 
per/sec), a feature which also minimizes the generation of side products. Eventually, however, 
once the optimal conditions for these reactions were ascertained, the N-alkylations could be 
scaled up in order to produce a greater quantity of product to be used in subsequent reaction 
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steps. Since it appeared that the N-alkylation of isatin had yet to be conducted using KF/alumina 
as a base, it was decided to examine the use of this basic catalyst in acetonitrile (ACN) under 
microwave irradiation. The microwave conditions initially varied temperatures and reaction 
times at 300 watts for the model reaction of isatin (32) and 1.5 equivalents of benzyl chloride 
(79) to yield 1-benzylindoline-2,3-dione (80). 
N O
O
H
N O
O
+
1 mmol 1.5 mmol
 KF/Alumina, ACN
M.W.
Cl
 
 The base KF/alumina was chosen because it is relatively easy to prepare, inexpensive, 
and a relatively strong base. The procedure utilized for the preparation of this solid base involved 
adding approximately 58 g of potassium fluoride to a 1 L round bottom flask and dissolving in 
100 mL of deionized water.
67
 Next ~100 g of aluminum oxide was added to the flask with 
continued stirring for 30 min. The water was then evaporated from the KF/alumina combination 
by rotary evaporation at 80ºC. The cement-like product was then scraped out of the round bottom 
flask and pulverized into a fine powder using a mortar and pestle. Finally, the product was 
transferred to a vacuum oven at 70-80ºC for 72 h to afford a fine white powder at approximately 
38 %/wt KF/alumina. The 38 %/wt calculation compares to the 40 %/wt KF/alumina sold by 
Sigma-Aldrich for $1.92 per gram ($48 for 25 g), whereas the 38 %/wt KF/alumina prepared 
from KF and aluminum oxide both provided by Sigma-Aldrich only totals $0.24 per gram.  
Given that the results of these N-alkylation reactions using either sample of base are almost 
32 79 80 
 
36 
 
identical (inferred by TLC), the prepared sample of KF/alumina was chosen to initiate the N-
alkylation process study.  
 As shown in Table 2 below, the parameters for the microwave assisted N-alkylation of 
isatin using benzyl chloride and KF/Al2O3 in ACN were progressively modified in order to 
achieve 100% completion. In each scenario, approximately 0.3398 mmol of isatin (0.050 g) was 
added to a 10 mL microwave vial along with 15 equivalents of KF/Al2O3 (0.779 g), 1.5 
equivalents of benzyl chloride and 5 mL of acetonitrile. The relative equivalency of KF/Al2O3 is 
based upon the fact that only the KF is reactive and the Al2O3 is a solid support. Thus the amount 
of KF for any given reaction is determined by the percent by weight of KF/Al2O3 which was 
calculated to be approximately 38%. To calculate the total grams of KF/Al2O3 required for ~15 
equiv. of the active reagent KF, first, the moles of KF  were determined to be 5.1 mmol by 
multiplying 15 times the molarity of isatin which is 0.3398 mmol. Further using the molecular 
weight of potassium fluoride (58.1 g/mol), the number of grams of KF alone needed for 15 
equiv. was figured to be approximately 0.296 g. However, because the KF and alumina are 
temporarily fused together, the total amount of KF/Al2O3 solid needed to include 0.296 g of KF 
could be determined by allowing 0.296/X = 0.38. Finally, the total amount of KF/Al2O3 was 
calculated to be X = 0.779 g based on the 38 %/wt. ratio of KF to KF/Al2O3. Initially it was not 
known if the KF/Al2O3 base could be used stoichiometrically or catalytically, and it was initially 
assumed that it might be capable of acting catalytically. However, it was eventually established 
that 15 equiv. of the base was optimal for achieving complete conversion of isatin into the 
corresponding N-benzylisatin derivative at 180ºC for 25 min under microwave irradiation. Going 
from the lowest temperature and time at 120ºC for 10 min to the highest temperature and time at 
180ºC for 25 min, the ratio of starting material to product was determined as the temperature was 
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increased by 20˚C increments and the time of reaction was varied between 10 and 25 min for 
each temperature interval. TLC analyses of the reaction mixtures were conducted as well as 
GC/MS analysis for the ratio of starting material (isatin) versus product (N-benzyl isatin) 
determined directly from aliquots of the crude reaction mixtures. Table 2 summarizes a direct 
correlation between temperature and time to the complete conversion into the desired N-
substituted product. Thus, as the time was increased from 10 to 25 min in each temperature 
setting, the turnover of product was increased. In addition, as the temperature was gradually 
increased there was noted a significant increase in product formation as well. In trial 1, the least 
amount of product conversion was noted at 120ºC, wherein the temperature was inadequate to 
overcome the activation energy barrier despite allowing further reaction time. In trial 2, at 140ºC 
there was a 9% increase in product generation due to the 15 min increase in reaction time. 
Likewise, in trial 3, at 160ºC the greatest product conversion was achieved providing only 3% 
starting material impurity at 25 min reaction with a 14% increase in product generation overall. 
Finally, 99% conversion was achieved at 180ºC for 25 min in trial 4. Once a time and 
temperature was found for optimal reaction conditions, the amount of base was also assessed for 
product generation by using 5 equiv. (trial 5) and 10 equiv. (trial 6) of KF/Al2O3 at 180ºC for 25 
min and GC/MS analysis was taken on the crude reaction mixtures showing 84:16 and 63:37 
ratios of isatin versus N-benzyl isatin for each reaction, respectively. This indicated that a 
seemingly excessive, 15 equiv. of KF/Al2O3 base was needed for the microwave reactions to go 
to completion at 180ºC and 25 min. Even though an optimal temperature and time was finally 
found, the “upper end” 180ºC temperature and relatively long reaction time of 25 minutes are 
certainly not ideal for a facile, microwave-accelerated reaction, and leaves room for 
improvement. One further improvement might entail the use of potassium iodide (KI) as a 
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catalyst, and performing the reaction in other polar aprotic solvents such as dimethylformamide 
(DMF) to facilitate this nucleophilic substitution onto a benzylic chloride. 
Table 2: Ratio of Isatin versus N-Benzyl Isatin via Microwave Irradiation  
 Time (minutes) 
                                        10                                    25 
 Temperature (ºC) Ratio (Isatin:N-benzyl isatin) 
Trial 1 120 34:66 33:67 
Trial 2 140 28:72 19:81 
Trial 3 160 17:83 3:97 
Trial 4 180 6:94 1:99 
Trial 5 (5 equiv. 
KF/Al2O3) 
180  84:16 
Trial 6 (10 equiv. 
KF/Al2O3) 
180   63:37 
 
 After ascertaining “optimal” conditions for effecting the N-benzylation of isatin under 
microwave irradiation, these conditions were employed to conduct other N-alkylation reactions 
using the isatin (32) scaffold and solid supported KF/alumina base to produce the desired N-
alkylated isatins 6. 
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N O
O
H
N O
O
R
X
R
+
1.5-2.0 equiv.,
X = Br, Cl
1. KF/Alumina (~15 equiv.)
2. Acetonitrile
Microwave: 180ºC, 25 mins.
 
As concluded from the microwave N-benzylation trials, approximately 15 molar 
equivalents of KF/alumina were needed in order to drive the N-alkylation of isatin to completion 
at 180˚C and 25 minutes reaction time. The reactions were prepared using approximately 0.3398 
mmol of isatin (0.050 g) in a 10 mL microwave vial along with 15 equivalents of KF/Al2O3 
(0.773 g) and 1.5 equivalents of each alkyl halide in 5 mL acetonitrile. The crude products were 
separated from the solid support by vacuum filtration and then washed with cold solvent and the 
purity confirmed by TLC analysis and melting point comparison with known values if available. 
The percent yield results and melting points for these reactions are reported in Table 3 below 
along with the structure of the product of interest.   
Table 3: N-Alkylation of Isatin Via Microwave Irradiation 
Final Product Melting Point Literature Melting 
Point 
Percent yield 
                             80  
126-131˚C 
 
126-127˚C
68
 
 
91% 
                             81  
122-126˚C 
 
132-133˚C
68
  
 
94% 
N O
O
N O
O
O
O
32 6 
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                             82 
 
 
184-189˚C 
 
N/S 
 
97% 
                             83  
147-151˚C 
 
N/S 
 
94% 
*N/S = product has not been synthesized before in literature 
 It is again emphasized that the products from the table above are the results from 
microwave synthesis on a small scale (due to the large amount of KF/alumina required) and 
these reactions could later be scaled up using conventional heating so as to provide sufficient 
amounts of product for further synthetic steps and/or biological screening. However, it is 
noteworthy to mention that the microwave synthesis reactions produced high yields and the 
melting points were very close to those reported in the literature. 
 
N-Alkylation of Isatin via Conventional Heating 
The following reaction scheme shows the method for N-alkylation of isatin (32) on a 
larger scale employing conventional heating to afford the desired N-alkylated isatins 6.  
Interestingly, when conducting the reactions on a larger scale, it was found that much less base 
was needed in order to ensure that each reaction went to completion in a reasonable time frame. 
Under these conditions, isatin was refluxed in acetonitrile using 6 equivalents of KF/Al2O3 for an 
average of 10 hours for 4 of the 5 products shown in Table 4.   
N O
O
Cl
Cl
N O
O
F
F
 
41 
 
N O
O
H
N O
O
R
X
R
+
1.5 equiv.
X = Cl, Br
1. KF/Alumina (~6 equiv.)
Refluxed in ACN
Rxn time: ~12 h
R = CH2 CH2
FF
CH2
ClCl
CH2
O O
* ***
80 838281
 
 As a point of information, it is noteworthy to mention that the formation of compound 85 
occurs by way of Michael reaction and not a simple SN2 reaction. In this case, refluxing isatin 
(32) with KF/Al2O3 and tert-butyl acrylate in acetonitrile afforded the ester 84 as an oily product, 
which was confirmed by GC/MS analysis. However, during the course of work-up and 
recrystallization from 2-propanol the ester 84 underwent adventitious hydrolysis to form the acid 
85 shown. 
 
N O
O
H
N O
O1. KF/Alumina (~6 equiv.)
2. tert-butyl acrylate (~1.5 equv.)
Refluxed in ACN
Rxn time: ~1.5 h
OO
N O
O
OHO  
32 
6 
85 
84 32 
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In Table 4 below, the products along with their melting point and percent yields are 
presented and compared to literature melting points where available.   
Table 4: N-Alkylation of Isatin Via Conventional Heating 
Final Product Melting Point Literature Melting 
Point 
Percent yield 
                              80  
128-133˚C 
 
126-127˚C
68
 
 
 
88% 
                              81  
124-129˚C 
 
132-133˚C
68
 
 
97% 
                              82 
 
 
175-180˚C 
 
N/S 
 
66% 
                              83  
154-156˚C 
 
N/S 
 
84% 
                                    85 144-149˚C  
N/S 
 
18% 
 *N/S = product has not been synthesized before in literature 
All of the compounds shown in Table 4 and Table 5 below were either sufficiently pure 
from work-up for complete characterization or were further purified by recrystallization if 
N O
O
N O
O
O
O
N O
O
Cl
Cl
N O
O
F
F
N O
O
O
OH
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necessary. Ultimately, all compounds were shown to be pure by GC/MS measurements as well 
as by TLC analysis and their identities secured by 
1
H and 
13
C NMR analyses (vide infra).  
In addition to the N-alkylation of isatin itself, a similar series of reactions was then 
conducted on 5-chloroisatin (86), purchased from Sigma-Aldrich, to produce the corresponding 
5-chloro-N-alkylated isatins 87. 
N O
O
H
N O
O
R
X
R
+
1.5 equiv.
X = Cl, Br
1. KF/Alumina (~6 equiv.)
2. Acetonitrile
Refluxed in ACN
Rxn time: 26 h
Cl Cl
  
The results are summarized in Table 5 wherein the reactions were refluxed for 
approximately 26 hours in the presence of 6 equivalents of KF/alumina. The extended reaction 
times are presumably attributable to the electron withdrawing effect of the chlorine atom, which 
weakens the nucleophilicity of the isatin salt. To date, none of the compounds listed in Table 5 
have known melting points or have been previously synthesized in literature. 
 
 
 
 
 
 
86 87 
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Table 5: N-Alkylation of 5-Chloroisatin Via Conventional Heating 
Final Product Melting Point Literature Melting 
Point 
Percent yield 
                             88  
134˚C 
 
N/S 
 
65% 
                             89  
130-135˚C 
 
N/S 
 
87% 
                             90 
 
 
233-235˚C 
 
N/S 
 
53% 
                             91  
172-177˚C 
 
N/S 
 
89% 
*N/S = product has not been synthesized before in literature 
 
NMR Analysis of N-Substituted Isatins 
All of the compounds made by conventional heating listed in Tables 4 and 5, were 
achieved in moderate to high yields with relative ease. The N-alkylated isatins and N-alkylated 5-
chloroisatin molecules prepared by conventional heating were further characterized by 
1
H and 
13
C NMR spectroscopy using the Bruker Avance 300 MHz NMR. The samples prepared using 
conventional heating were primarily chosen for NMR analysis over the samples prepared by 
microwave irradiation simply due to the abundance of product generated. Prior to the analysis of 
the substituted molecules, a thorough analysis of the chemical shifts of isatin itself was 
N O
OCl
N O
O
O
O
Cl
N O
O
Cl
Cl
Cl
N O
O
F
F
Cl
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completed and compared to shifts reported in the literature and were found to agree accordingly.  
All of the following spectra generated were analyzed and expanded using SpinWorks 3.1.   
 The 
1
H NMR spectrum of isatin (Sigma-Aldrich) is presented below in Figure 1. There 
are clearly five signals which represent the five protons found on the isatin molecule.  
 
The signal furthest downfield is a singlet peak at 11.04 ppm and its downfield shift is  
due to a strong deshielding caused by the effect of the nitrogen atom bonded to the proton.  
There is a triplet at 7.59 ppm (J = 7.71Hz) and a doublet at 7.50 ppm (J = 7.59Hz) which are 
assigned to the protons labeled 5 and 4 in Figure 6 respectively. Additionally, there is another 
triplet signal at 7.07 ppm (J = 7.55Hz) and doublet at 6.91 ppm (J = 7.83Hz) which correspond 
to the protons 6 and 7 above. The signals from protons 4 and 5 appear further downfield due to 
the proximity to the carbonyl group being in resonance to the carbons of the corresponding 
protons 4 and 5. For reasons which are not clear at this point none of the signals exhibit 
secondary splitting or show any signs of meta coupling. Finally there are two singlets upfield 
which are both due to the solvent DMSO-d6 which appear at 3.38 ppm and 2.52 ppm.  
N O
O
H
1
H
H
H
H
6
7
4
5
Figure 6 
 
46 
 
The 
13
C NMR spectrum of isatin (32) is presented in Figure 7 below and shows eight 
signals which correspond to the eight carbons in the isatin molecule. The peak furthest downfield 
at 184.4 ppm correlates to the C-3 ketone carbonyl group of the isatin molecule, while the amide 
carbonyl appears at 159.3 ppm. Carbons 3a (117.8 ppm) and 7a (150.7 ppm), like carbons 2 and 
3 are quaternary carbons and consequently do not appear in the 
13
C DEPT spectrum. The 
remaining signals for carbons 4-7 fall within the aromatic region of the spectrum and appear at 
138.3, 124.6, 122.7, and 112.8 respectively. For reference, the solvent signal appears at 39.6 ppm 
for DMSO-d6. The 
13
C data above are consistent with the shifts reported in the literature by 
Gassman completed in dimethyl-sulfoxide-d6 solvent, wherein the values in descending order are 
184.6, 159.5, 150.9, 138.5, 124.8, 122.9, 117.9, and 112.4 
ppm.
12
    The NMR spectra for the N-alkylated products were similarly analyzed as well, and as 
expected there are several shifts of the original carbon peaks due the addition of a benzyl group 
at the nitrogen atom, along with of course the appearance of new proton and carbon signals. 
N O
O
H
1
2
3
4
5
3a
6
7
7a
Figure 7 
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4
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H
H
HH
H
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6
7
H8
H
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N O
O
11
H
Cl
H
H 8
10
4
H
H
HH
H
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11
8
6
H
7
H
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Compound 80 was prepared by refluxing isatin, KF/alumina base, and benzyl chloride in 
acetonitrile for 2 h until confirmation of product completion by TLC. The product above was 
then recrystallized from hexanes and dichloromethane and isolated as bright orange crystals.  
This compound was of interest to our research due to the potential of the benzyl ring to extend 
and possibly form hydrophobic contact with the S2 subsite of a caspase binding site. In the 
1
H 
NMR spectrum of 80 the solvent used was CDCl3 which appears as a singlet at 1.67 ppm. There 
is a doublet of doublets which appears downfield at 7.62 ppm (J = 7.50Hz, 0.75Hz) and is likely 
due to proton 4. Furthermore, there is a triplet of doublets at 7.5 ppm (J = 7.83Hz, 1.32Hz) 
representing proton 5. Proton 7 experiences meta splitting with proton 5 just as proton 6 
experiences meta splitting with proton 4. This is supported by the fact that secondary splitting for 
protons 4 and 6 are both 0.75Hz, while there is a secondary splitting of 1.32Hz for proton 5, 
however there is no secondary splitting for proton 7, for reasons not known. Thus, proton 6 
appears as a triplet of doublets signal at 7.10 ppm (J = 7.53Hz, 0.75Hz) and proton 7 appears as a 
doublet at 6.8 ppm (J = 7.92Hz). Finally, there is a multiplet due to the five protons on the 
benzyl ring which appears at 7.41-7.30 ppm while a singlet signal appears at 4.95 ppm due to the 
two equivalent benzylic protons 8. 
 1-benzylindoline-2,3-dione (80) 1-benzyl-5-chloroindoline-2,3-dione (88) 
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Compound 88 was prepared by refluxing 5-chloroisatin, KF/alumina, and benzyl chloride 
in acetonitrile for 47 h, after which the final product was then recrystallized from ethanol. When 
comparing the 
1
H and 
13
C NMR spectra of 80 to its 5-chloro derivative 88 there are several 
differences worth mentioning. In the proton NMR spectrum which was also done in CDCl3, there 
is a strong doublet at 7.57 ppm (J = 2.22Hz) which is attributable to proton 4 which is ortho to 
the 5-chloro position and experiences meta splitting due to its hydrogen-hydrogen interaction 
with proton 6. Furthermore, a doublet of doublets‟ signal can be seen at 7.45 ppm (J = 8.43Hz, 
2.21Hz), which is due to proton 6 coupling with proton 7 and meta splitting with proton 4, while 
proton 7 appears as a doublet signal at 6.75 ppm (J = 8.34Hz). Similarly to the proton NMR 
spectrum for 80 a multiplet is visible at 7.37-7.31 ppm due to the aromatic hydrogens from the 
benzyl ring and a singlet signal is observed at 4.94 ppm due to the methylene protons 8. 
The 
13
C NMR spectrum of 80 is shown below which gives 13 signals. 
 
 
N O
O
1
2
3
4
5
6
7
8
3a
7a
9 10'
11
11'
12
10
Figure 8 
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In Figure 8 the CDCl3 signal appears at 77.04 ppm.  There are two carbonyl peaks which 
are located at 183.2 ppm for carbon 3 and 158.3 ppm for carbon 2. In addition the remaining 
aromatic peaks for carbons 3a-7a are consistent with those of the isatin molecule carbon shifts 
and only change slightly, appearing at 117.7, 138.3, 125.4, 123.84, 111.0, and 150.74 ppm 
respectively. In addition the spectrum includes an aliphatic peak due to carbon 8, which appears 
at 44.1 ppm. Likewise there are an additional four signals which correspond to the benzyl phenyl 
ring. The signal for the quaternary carbon 9 appears at 134.54 ppm and does not appear in the 
13
C DEPT spectrum. The carbons 10 and 10‟ are symmetric and are shown as a large intense 
peak at 127.4 ppm, as does the signal for carbons 11 and 11‟ which appears at 129.1 ppm.  
Carbon 12 appears at 128.2 ppm in the spectrum.   
 
N O
O
11
H
H
H
H
12
8
4
5
F
H
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F 11
6
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8
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O
8
H
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H
11
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4
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H
6 H
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Compound 83 was prepared by refluxing isatin, KF/alumina and 2,6-difluorobenzyl 
bromide in acetonitrile for approximately 20.5 h after which time the product was isolated and 
recrystallized from hexanes and dichloromethane to form miniscule brown crystals. The idea of 
incorporating the “2,6-difluorobenzyl” moiety was derived from the protease inhibitor Q-VD-
1-(2,6-difluorobenzyl)indoline-2,3-dione 
(83) 
1-(2,6-difluorobenzyl)-5-
chloroindoline-2,3-dione (91) 
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OPh wherein the difluorophenoxy group serves as a terminal “war-head” and is thought  to 
covalently react with the active-site cysteine residue of the enzyme due to its electrophilic nature.  
The 
1
H NMR spectrum of 83, was collected using CDCl3 as the solvent. There is a doublet of 
doublets signal at 7.60 ppm (J = 7.47Hz, 0.75Hz) which is due to the proton 4 labeled which 
undergoes meta splitting with proton 6. Similarly to the 
1
H spectrum for 1-benzylindoline-2,3-
dione 80, the next peak is a triplet of doublets which occurs at 7.53 ppm (J = 7.83Hz, 1.32Hz) 
due to proton 5 which also undergoes meta splitting with proton 7. A set of multiplet peaks can 
be seen from 7.37-7.26 ppm in the spectrum which is a result of hydrogen coupling from the 
equivalent protons 11 and proton 12 within the benzyl ring. A suspected doublet signal for 
proton 7 is not distinctive in the spectrum and could possibly be hidden in the multiplet signal or 
abnormally large triplet signal seen at 6.94 ppm. Following suit from the isatin molecule and 80, 
a triplet of doublets‟ signal appears at 7.10 ppm (J = 7.52Hz, 0.57Hz) due to proton 6, which 
experiences meta splitting with proton 4. Dissimilar from the former compounds, another triplet 
signal appears at 6.94 ppm (J = 8.22Hz) which is a result from proton 12 coupling with protons 
11. Lastly, a singlet from the pair of methylene protons 8 appears at 5.03 ppm which is again 
consistent with the 
1
H NMR spectrum for compound 80. 
Compound 91 was prepared by refluxing the 5-chloroisatin in acetonitrile with 
KF/alumina base and 2,6-difluorobenzyl bromide for 24 h. The product was then recrystallized 
from dichloromethane and hexanes to afford ruby red crystals. The 
1
H NMR spectrum of the 5-
chloro derivative 91, shows a doublet at 7.57 ppm (J = 7.07Hz) due to proton 4, which is isolated 
between the chlorine atom and a quaternary carbon. Similar to compound 88, there is a doublet 
of doublets signal at 7.50 ppm (J = 2.27Hz) which is due to proton 6 and its meta splitting with 
proton 4. Proton 7 is shown at 6.75 ppm (J = 8.55Hz) in the spectrum as a doublet. A triplet 
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signal appears at 6.96 ppm (J = 8.15Hz) due to proton 12 coupling with protons 11, and a 
multiplet is seen at 7.39-7.28 ppm which is due to coupling between protons 11 and 12 on the 
benzyl phenyl ring. 
 Figure 9 below shows the 
13
C spectrum for 1-(2,6-difluorobenzyl)indoline-2,3-dione 
(83), and displays 14 signals using CDCl3 as the solvent. 
 
 
 In the 
13
C spectrum for compound 83 there are seven quaternary signals, as evidenced by 
their absence in the 
13
C DEPT spectrum. The two carbonyl signals from the isatin core appear at 
157.5 ppm for carbon 2 and 182.9 ppm for carbon 3 above. Carbons 3a and 7a appear at 117.74 
and 150.4 ppm, respectively, which is consistent with the isatin carbon shifts for those positions.  
Carbons 10 and 11 experience strong electron-withdrawing effects from the two attached 
fluorine atoms and unique fluorine-carbon splitting which results in a broad set of doublet of 
doublets at 159.9 ppm and 163.2 ppm (J = 29.06Hz). Carbon 9 appears as a triplet signal at 
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110.25 ppm (J = 66.09Hz) due to it being split by the two fluorine atoms attached to carbons 10 
and 11 and it is also overlapped by carbon 7 at 110.3 ppm in the spectrum which appears as a 
singlet. Carbons 12 and 12‟ appear as a more narrow set of doublets of doublets centered at 
111.8 ppm (J = 29.58Hz) which is also due to splitting from nearby fluorine atoms. Another 
triplet signal can be seen at 130.52 ppm (J = 40.59Hz) for carbon 13 which is a direct results of 
splitting by the fluorine atoms again located on carbons 10 and 11 which are meta to carbon 13.  
Carbons 4-6 fall into the expected range for the isatin and which are at 138.4, 125.3, and 123.8 
ppm respectively. The methylene carbon 8 is found within the aliphatic region of the spectrum at 
32.2 ppm. 
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Compound 82 shown above was recrystallized from hexanes and chloroform as bright 
orange miniscule crystals. This molecule is similar to the difluoro derivative 83, but instead 
incorporates slightly larger chlorines to resemble the electrophilic moiety present in Q-VD-OPh 
which might also be able to interact with the active-site of a targeted enzyme. The 
1
H NMR 
spectrum of 82 was done using CDCl3 as the solvent. The proton spectrum of compound 82 
1-(2,6-dichlorobenzyl) 
indoline-2,3-dione (82) 
1-(2,6-dichlorobenzyl)-5- 
chloroindoline-2,3-dione (90) 
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appears to be similar to that of 1-(2,6-difluorobenzyl)indoline-2,3-dione (83) however there are 
some slight differences. Similar to the spectrum of the previous compound there is a doublet of 
doublets at 7.61 ppm (J = 7.47 Hz, 0.75Hz) which is due to proton 4 and its meta splitting to 
proton 6, and soon after there is a triplet of doublets signal at 7.46 ppm (J = 7.83Hz, 1.35Hz) due 
to proton 5 with meta splitting to proton 7. However, unlike the previous compound, instead of a 
multiplet, two doublets appear at 7.39 ppm (J = 7.92Hz) and also at 7.28 ppm (J = 7.23Hz) 
(which are slightly overlapping with the following triplet signal) due to protons 11 on the benzyl 
phenyl ring. Likewise, the triplet signal which corresponds to the benzyl phenyl ring for proton 
12 appears at 7.26 ppm (J = 6.51Hz). Proton 7 appears as a doublet at 6.75 ppm (J = 7.89Hz) and 
proton 6 appears as a triplet of doublets signal at 7.08 ppm (J = 7.56 Hz, 0.57Hz). Lastly, as 
expected, protons 8 appear as an intense singlet at 5.26 ppm. 
Compound 90 was prepared by refluxing 5-chloroisatin in acetonitrile with the 
KF/alumina base and 2,6-dichlorobenzyl bromide for 24 h to yield reddish-orange crystals. The 
1
H NMR spectrum of 90 was obtained using DMSO-d6 as the solvent. There is a doublet of 
doublets signal at 7.71 ppm (J = 8.49Hz, 2.30Hz) due to proton 5 which experiences meta 
splitting with proton 4. Likewise proton 4 appears as a singlet signal which also shows meta 
splitting at 7.66 ppm (J = 2.32Hz). Unlike the proton spectrum for compound 82, instead of two 
doublets  for protons 11, there exists only one large and intense doublet signal at 7.54 ppm (J = 
8.01Hz) due to the symmetrical protons 11‟ coupling with proton 12. Proton 12 appears as a 
triplet signal at 7.42 ppm (J = 7.92Hz) and finally there is an intense singlet signal at 5.13 ppm 
due to the pair of protons 8. 
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 The 
13
C spectrum of 1-(2,6-dichlorobenzyl)indoline-2,3-dione 82 was obtained in CDCl3 
and shows 13 signals in Figure 10. The carbons labeled 2-7a on the isatin core were observed to 
be very similar to the values reported in previous work done by Gassman.
12
 The dichloro-
substitution on the benzyl ring had contrasting effects when compared to the carbon shifts for the 
difluoro-moiety. The quaternary carbon 9 which appears at 129.2 ppm is overlapped by the 
symmetrical carbons 11 and 11‟ which appear as an intense singlet peak at 129.1 ppm, and 
expectedly disappears in the 
13
C DEPT spectrum of the molecule. Carbons 10 and 10‟ are also 
quaternary carbons which disappear in the DEPT spectrum and both appear as a singlet peak 
around 136.4 ppm. Carbon 12 exists around 130.3 ppm in the aromatic region of the spectrum, 
while carbon 8 is shown at 40.3 ppm in the aliphatic area. 
N O
O
1
2
3
4
5
6
7
8
3a
7a
9
10'
11
11'
12
10
Cl
Cl
Figure 10 
 
55 
 
N O
O
11
H
H
H
H
8
45
8
6
O
O
H
H H
H
HH H
10
11
7 10
11
                                                   
N O
O
O
O
Cl
H
H
H
H
H
HH H
H
H
7
8
8
4
10 10
116
11
11
 
  
 
Compound 81 was obtained upon refluxing isatin in acetonitrile with 6 equiv. of 
KF/alumina base and 1.5 equiv. of ethyl bromoacetate for approximately 21 h until complete 
formation of product was achieved. After simple filtration and washing, the identity of the 
product was verified by TLC and melting point analysis and no other purification method was 
employed. The acetate group on our isatin scaffold was introduced due to its similarity to an 
aspartic acid residue which is a key recognition motif for protein cleavage by way of presumed 
effector capsases and due to the susceptibility of the carbonyl to be attacked by a cysteine 
nucleophile. The 
1
H NMR spectrum of compound 81 was obtained using CDCl3 as the solvent.  
There is a doublet of doublets signal at 7.64 ppm (J = 7.56Hz, 0.75Hz) which is due to the 
aromatic proton 4 meta splitting with proton 6. At 7.6 ppm (J = 7.83Hz, 1.35Hz) a triplet of 
doublets signal appears which is also due to an aromatic proton 5 meta splitting with proton 7.  
In addition protons 7 and 6 appear as a doublet at 6.81 ppm (J = 7.98Hz) with no secondary 
splitting observed, and a triplet of doublets at 7.16 ppm (J = 7.54 Hz, 0.72Hz), in that order. The 
symmetrical protons 8 appear as an intense singlet peak at 4.49 ppm, while the aliphatic protons 
Ethyl 2-(2,3-dioxoindolin-1-yl) 
acetate (81) 
Ethyl 2-(5-chloro-2,3-dioxoindolin-
1-yl)acetate (89) 
 
56 
 
10 is shown as a quartet at 4.25 ppm (J = 7.15Hz). The three equal protons 11 appear furthest 
upfield as a triplet signal at 1.29 ppm (J = 7.08Hz). 
Compound 89 was prepared by refluxing 5-chloroisatin in acetonitrile with KF/alumina 
base and ethyl bromoacetate. The 
1
H NMR spectrum of 89 was obtained using DMSO-d6 as the 
solvent. There is a doublet signal at 7.75 ppm (J = 8.55Hz, 2.22Hz) due to proton 6, which 
experiences meta splitting with proton 4. The latter appears a singlet signal at 7.67 ppm (J = 
2.01Hz). Another doublet signal is seen at 7.25 ppm (J = 8.46Hz) due to proton 7 coupling with 
proton 6. The protons 8 are seen as an intense singlet peak in the aliphatic region of the spectrum 
at 4.63 ppm. In the same region, protons 10 couple with protons 11 and the signal for the former 
appears as a quartet at 4.17 ppm. Lastly, furthest upfield exists a triplet signal due the protons 11 
at 1.22 ppm. Not surprisingly the shifts for 89 compare very closely to those of compound 81, 
with the exception of the absence of the proton substituted by the chlorine atom.  
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The 
13
C spectrum of compound 81 (shown in Figure 11 above) was obtained in DMSO-
d6 and showed 12 signals for 12 carbons in the molecule. Not surprisingly the carbons labeled 2-
7a are all very similar to literature values based on the isatin core as reported in previous work by 
Gassman et al.
12
 Moreover, carbons 8, 10, and 11 all appear in the aliphatic region of the 
13
C 
spectrum at 41.2, 61.3, and 14.0 ppm, respectively. Carbon 9 appears much further downfield at 
167.34 ppm due to the strong electronegative pi cloud from the oxygen atom which is double 
bonded to the carbon causing strong electron withdrawing effects. 
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Compound 85 was prepared by refluxing isatin acetonitrile with KF/alumina base and 
tert-butyl acrylate for approximately 1.5 h to give a reddish-brown oil which was purified by 
column chromatography using silica and identified as the tert-butyl compound 84 by GC/MS 
analysis. After standing for some time, the oil was recrystallized from 2-propanol to give only 
18% yield of what was later determined to be compound 85. At this point it is not clear at which 
point the whether the tert-butyl group of compound 84 was hydrolyzed into the carboxylic, 
assuming both compounds were not initially produced from this reaction. Unlike the previous 
SN2 reactions, the mechanism for this specific molecule occurs by way of a Michael addition, in 
which the nitrogen nucleophile attacks the β-carbon of the α,β-unsaturated carbonyl of the 
acrylate. Furthermore, this compound may have potential as a caspase inhibitor due to its 
susceptibility to be attacked by a cysteine nucleophile at the carbonyl. The 
1
H NMR spectrum of 
compound 85 was obtained using DMSO-d6 as the solvent.  There is a singlet signal at 12.41 
ppm which is due to the hydroxyl proton 10 of the carboxylic acid.  At 7.66 ppm (J = 7.76Hz) a 
triplet signal appears which is due to proton 5 which couples with proton 4 seen as a doublet 
signal at 7.54 ppm (J = 7.32Hz).  At 7.12 ppm (J = 7.47Hz) a triplet signal appears due to proton 
6 which couples with protons 5 and 7, in which proton 7 appears as a doublet signal at 7.24 ppm 
tert-butyl 3-(2,3-dioxoindolin-
1-yl)propanoate (85) 
84 
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(J = 7.89Hz). Protons 8 and 9 appear in the aliphatic region of the spectrum both as triplet signals 
at 2.62 ppm (J = 7.19Hz) and 3.89 ppm (J = 7.28 Hz) respectively. The 
13
C spectrum of 
compound 85 (shown in Figure 12 below) was obtained in DMSO-d6 and showed 11 signals.  
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The carbons labeled 2-7a on the isatin core were observed to be very similar to the values 
reported in previous work done by Gassman et al. and are given in descending order as 183.4, 
158.0, 150.4, 138.1, 124.4, 123.1, 117.5, and 110.9 ppm.
12
 Additionally, the carbons labeled 8 
and 9 appear in the aliphatic region of the carbon spectrum at 31.44 and 35.6 ppm, respectively.  
The carbonyl carbon of the carboxylic acid appears at 172.21 ppm.  
Figure 12 
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EAS Reactions for Isatins and Oxindole 
As mentioned previously, the nitro-group of the “5-nitro-2,6-difluoro” moiety of 
compound 75 prepared by H. Abdallah (specifically showing up to 5 μM activity, preventing cell 
death in Jurkat T cells), as well as the efficacy of the 5-nitroisatin lead described by SmithKline 
Beecham, is thought to play a vital role in the inhibition of caspases. It is not known exactly how 
or if the nitro-group binds within a specific subsite of a caspase enzyme, however, the nitro-
group as well as other strong electron withdrawing groups were desired at the C-5 position of 
isatin and oxindole deriviatives in order to acquire low micromolar and even possibly nanomolar 
inhibitory concentrations against apoptotic cells. In this research, electrophilic aromatic 
substitution reactions upon isatin were performed to incorporate a nitro (-NO2) group at the C-5 
position. The reaction proceeded by adding a solution of isatin (32) in concentrated sulfuric acid 
(H2SO4) dropwise to a solution of potassium nitrate (KNO3) in concentrated sulfuric acid at 0ºC, 
over a time period of 1 h.
19
 The reaction produced 5-nitro-indoline-2,3-dione (33) as an orange 
solid with a yield of 81% and mp of 249-254ºC which compares exactly to the literature mp of 
249-254ºC
69
. 
N O
O
H
N O
H
1. H2SO4, KNO3
2. H2SO4, H2O
Temp: 0-4ºC
O2N
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 The 5-nitroisatin was confirmed by 
13
C NMR analysis in DMSO-d6 solvent and was 
compared to the 
13
C NMR spectra for 5-nitroisatin obtained by Gassman,
12
 using DMSO-d6 
solvent, and furthermore both of these spectra were compared to the 
13
C NMR spectra of isatin 
(Sigma-Aldrich) (Table 6 below) to compare chemical shifts created by the addition of the nitro-
32 33 
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group. It was observed that the replacement of the C-5 proton with the nitro group resulted in 
significant shifts at C-4, C-5, C-6, and C-7 with a difference in electron density of -5.2, +18.0, -
3.2, and +4.5, respectively. Furthermore, when comparing the 
13
C NMR of compound 33 to the 
13
C of 5-nitroisatin reported by Gassman, each carbon shift matches almost identically with a 
difference in shift </= 0.2 ppm as shown in Table 6 below. 
Table 6: Chemical Shifts for Isatin and 5-nitroisatin 
 C-2 C-3 C-3a C-4 C-5 C-6 C-7 C-7a 
Isatin 159.3 184.4 117.8 138.3 124.6 122.7 112.2 150.7 
5-nitroisatin
12
  159.9 182.4 118.2 133.2 142.7 119.6 112.6 155.3 
Compound 33 159.8 182.4 118.0 133.1 142.6 119.5 112.5 155.2 
 
Since a 5-nitro-N-benzylisatin molecule had never been successfully synthesized or 
tested by the Ketcha research group, the desire to synthesize this molecule was fueled by the 
promising results obtained by SmithKline Beecham of their 5-nitro-N-benzylisatin compound 
which provided 0.25 μM activity against caspase-3. In addition, if successfully accomplished, the 
anticipated compound could be further functionalized at the C-3 position by adding the 2,6-
diflourophenyl group via Wolff-Kishner reduction of the C-3 carbonyl, followed by aldol 
condensation to create the benzylidene oxindole. This molecule could then be tested against 
Jurkat T cells and compared to compound 75, which lacks the N-benzyl group. Therefore, the N-
alkylation was attempted on 5-nitroisatin (33) in order to add functionality upon the core 
structure. However, after several attempts at N-alkylation of the former molecule using 
KF/alumina base and benzyl chloride as the alkylating reagent, the reaction was unsuccessful. A 
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possible explanation could be that the nitroisatin skeleton is susceptible to ring opening at the 
amide bond in a basic environment, as reported by Y. Torisawa et al.
36
 The latter group found 
that attempts at reducing 5-nitroisatin using Red-Al (5 equiv) or NaBH4 provided ring-opened 
products.
36
 However, using a milder base combination such as CuCO3/Cs2CO3 in anhydrous 
DMF they were indeed successful at alkylating 5-nitroisatin. Thus it can be speculated that the 
addition of the nitro group compromises the stability of isatin skeleton making it vulnerable to 
opening, and for future work, a weaker base may be necessary in order to perform N-alkylation 
reactions on 5-nitroisatins.  
 Due to the failed attempt at alkylating 5-nitroisatin, an alternative route was investigated 
where the pre-alkylated N-benzylisatin was nitrated in order to make the same molecule. The 
nitration of the N-benzylisatin (80) was attempted repeatedly using the method prescribed by K. 
Vine et al.,
19
 and furthermore attempted by way of the addition of concentrated nitric acid to a 
solution of the N-benzylisatin (80) in sulfuric acid, a method previously employed by Sumpter et 
al. on oxindole to afford 5-nitrooxindole.
70
 The efforts at isolating 5-nitro-N-benzylisatin (92) 
were finally abandoned after numerous repeats of Sumpter‟s nitration method and since the 
desired product could not be confirmed by GC/MS or melting point analysis. 
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 An alternative means of creating an electron withdrawing group at the C-5 position of the 
isatin/oxindole core can be achieved by synthesizing the oxindole sulfonamide via 
chlorosulfonation of oxindole as seen below. The multistep process of introducing this 
functionality on an isatin described earlier suggested the analogous reaction on an isatin would 
be preferable. If successful, the oxindole sulfonamide provides additional benefits compared to 
the 5-nitro derivative, given that it is not reducible in vivo, and can be further functionalized via a 
variety of amine groups to afford the corresponding sulfonamides which could possibly allow 
access to other subsites of a caspase enzyme.  
N O
H
N O
H
1. HClSO3, 0-68ºC
2. NH4OH, EtOH
H2NO2S
 
For these reasons, the oxindole sulfonamide was synthesized as opposed to the isatin 
sulfonamide due to fact that the isatin derivative would eventually be reduced to the oxindole 
derivative. To this end, oxindole (93) was slowly added to highly corrosive chlorosulfonic acid 
while maintaining the temperature below 30ºC for 1.5 h. Subsequently, the solution was heated, 
then allowed to cool, and finally added to an ammonium hydroxide and ethanol solution and 
allowed to stir overnight to afford 94. Unfortunately, the insoluble solid collected by vacuum 
filtration could not be identified by GC/MS, and furthermore the 
13
C NMR analysis showed an 
unidentified compound given by the addition of several peaks which are not consistent to the 
spectra analysis done by L. Sun et al.
71
 
 Nonetheless, further attempts at incorporating a relatively strong electron withdrawing 
group onto the isatin/oxindole benzene ring, led now to the direct nitration of oxindole (93).   
93 94 
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The 5-nitro-oxindole (95) was prepared and isolated by way of the Sumpter et al. method
70
 as 
mentioned above and provided a 23% yield of the desired nitrated product with a mp of 240-
243ºC, which compares to the literature mp of 240-241ºC
68
.   
N O
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Wolff-Kishner Reduction Results 
Following the pathway shown in Figure 5, the Wolff-Kishner reaction was performed on 
selected N-alkylated products previously described. Thus, using compounds 80, 83, and 88, the 
C-3 carbonyl of the isatin scaffold was reduced into a methylene group via the formation of a 
hydrazone intermediate to give N-substituted-indolin-2-ones 96. The Wolff-Kishner reaction 
proceeds by refluxing the isatin derivative 6 in 80 % hydrazine-hydrate for 3-5 hours followed 
by work up in 6N HCl and water to give the oxindole derivatives 96 presented in Table 7. 
N O
O
R
N O
R
1. NH2NH2
2. HCl, H2O
Reflux: 3-5 h
 
 
 
95 93 
6 96 
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Table 7: N-Substituted-Indolin-2-ones from Wolff-Kishner Reduction  
Starting Material Percent Yield Product mp Literature mp Product 
N/A oil  80-81˚C
72
 
95  157-162˚C  N/S 
76  103-105˚C  103-105˚C
72
 
*N/S = product has not been synthesized before in literature 
Compound 97 was isolated as an oil and could not be solidified even after several 
attempts at recrystallization. Therefore, the resultant oil obtained was used to perform the 
Knoevenagel condensation with 4-pyridincarboxaldehyde in ethanol and a catalytic equivalent of 
piperidine base. The reaction produced a black “tar-like” oil which was shown to be a mixture of 
the desired product and starting material by GC/MS analysis. To separate the compounds, a silica 
gel column was applied using 70% hexanes and 30% ethyl acetate as the mobile phase solvent.  
Unfortunately, the separation technique proved to be inadequate for the two compounds based on 
their Rf values.  
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Aldol Condensation Results 
The last synthesis step required to create a library of desired trisubstituted benzylidene 
compounds involves an aldol or Knoevenagel condensation reaction. Oxindole, N-substituted 
oxindole derivatives (shown in Table 7), as well as 5-nitro-indolin-2-one (95) were used to 
perform the Knoevenagel condensation reaction at the C-3 methylene group, so as to allow for an 
additional site of diversity which would facilitate regulation of properties such as selectivity 
amongst caspases. The design of these compounds was also based upon the previously discussed 
SAR studies of Q-VD-OPh and the micromolar activity demonstrated against Jurkat T cells 
using compounds 75, 77, and 78 (shown below) presented by Hagar Abdallah in previous years. 
Given the speculation that 5-nitro-2,6-difluoro-indolin-2-one (75) was active at 5 μM due to the 
electrophilicity created by the strong electron withdrawing effects of the two fluorine atoms 
extended from the C-3 position, combined with the electron withdrawing effects of the nitro-
group at the C-5 position, compound 75 was recreated to determine whether the inhibition 
activity shown against Jurkat T cells could be repeated, while the 2,6-difluoro derivative lacking 
the nitro group, 76 was also synthesized as an antagonist to 75.. The 2,6-dichloro analog 107 
extended from the C-3 position, held promise as a closely related alternative to the 2,6-difluoro 
derivative, even though it possesses slightly weaker electron withdrawing effects using similar 
halogen atoms. The 3,5-difluoro moiety seen in 108 was desired given that it retained the 
fluorine atoms but arranged at different positions in comparison to the known active compound 
75 in aspiration to gain equivalent or enhanced potency against caspases. Ideally, other strong 
electron withdrawing groups might prove effective and help to understand the expectations 
needed to increase binding affinity of these small molecules to targeted enzymes and therefore 
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compounds 103 and 104 were of interest due to the positioning of a nitro-group about the 
benzylidene ring.   
O2N
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Beyond designing benzylidene oxindole analogs bearing electron-withdrawing 
substituents which might mimic the effects of the 2,6-difluoro moiety, another set of analogs 
were prepared which exhibited the hydrogen bond accepting motifs demonstrated by the para-
methoxy benzylidene 77 and 4-pyridine benzylidene 78. Thus, compound 109 was created due to 
the hydroxyl group which also possesses a lone pair electrons which could partake in hydrogen 
bonding interactions. Additionally, compounds 105 and 106 incorporated a pyridine ring in 
which the position of the nitrogen is displaced about the benzylidene ring compared to 
compound 78, to survey the optimal location of the nitrogen atom. Finally, compound 110 does 
not possess any EWG or hydrogen bond accepting groups, but as such could serve as a baseline 
indicator of the necessity of such. The compounds in Table 8 below were prepared using the 
oxindole core 100 with aromatic aldehydes 101 in ethanol with a catalytic amount of piperidine 
base, usually at 90ºC for 3-5 hours to give the 3-substitued indolin-2-ones 75-76 and 103-110 
represented by 102E and 102Z, depending on their configuration. 
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Table 8: 3-Substituted-Indolin-2-ones from Knoevenagel Condensations  
Compound Percent 
Yield 
Melting Point Literature Melting 
Point 
Configuration 
(Z:E) 
                               103 82 251-252ºC 245-250ºC
73
 100:0 
                               104         90 244-246ºC   258ºC
74
  60:40 
                               105 75 206-209ºC 202-203ºC
75
 100:0 
                               106 36 161-165ºC N/S 60:40 
                               107 57 182-184ºC 179-181ºC
76
 100:0 
                               108 59 206-210ºC 202-205ºC
77
 100:0 
                               76 69 233-238ºC 213-218ºC
77
 100:0 
75 48 257-258ºC 251-255ºC
77
 100:0 
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109 44 193-195ºC 195ºC
78
 0:100 
                              110 66 172-175ºC 180-181ºC
79
 0:100 
*N/S = product has not been synthesized before in literature 
N
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 Temp: 90ºC, 3-5 h
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The 3-substituted indolin-2-ones 102 may exist in either the E or Z isomer about the exocyclic 
double bond depending on the characteristics of the substituents at the C-3 position.  
Identification of the E or Z isomers was determined using 
1
H NMR analysis due to the chemical 
shifts of the aromatic protons on the benzylidene ring (H-2‟ and H-6‟) or ortho-arylidene protons 
and the vinylic proton being significantly influenced by configuration. The vinylic proton (Hvin) 
is more deshielded in the E-isomer due to the influence of the C-2 carbonyl just as the ortho-
benzylidene protons (Ho) are shifted downfield due to the C-2 carbonyl as shown in Figure 13 
below. Therefore, in the Z isomer, the H-2‟ or H-6‟ protons occur in the range of 7.85-8.53 ppm 
compared to 7.45-7.84 ppm for the same protons in the E isomers.
75
 In some cases where the H-
2‟ and H-6‟ positions were substituted as in compounds 107, 75, and 76, only the influence of the 
vinylic proton was used to determine configuration, where the vinylic proton occurs about 7.55 
ppm in the Z isomer and 7.84 ppm in the E isomer.
80
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Figure 13-E/Z Configuration of 3-Substituted Benzylidenes 
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 In addition to the deshielding effects created by the carbonyl, other factors may influence 
the configuration of the benzylidene compounds. For example, in the case of 110, the E isomer is 
favored due to steric repulsion between the carbonyl group and the H-2‟ and H-6‟ protons of the 
phenyl ring in the Z form. Compound 109 tends to favor the E configuration as well which may 
be due to electrostatic repulsion between the C-2 carbonyl and the oxygen attached to the phenyl 
ring. However, most of the compounds observed showed 100% of the Z isomer which could be 
due to the attraction of the lone pair of electrons at the C-2 carbonyl for partial positive charges 
created at the carbons attached to electron withdrawing atoms such as –F, -Cl, and –NO2 upon 
the benzylidene ring. Compounds 106 and 104 possess either a nitrogen substitution in place of 
the third carbon incorporated into the phenyl ring (106) or an addition of atoms at the third 
carbon of the phenyl ring (104), and both provide a 60:40 ratio of the Z to E isomer based on the 
1
H NMR analysis which could possibly be supported by the fact that previous investigators have 
observed equilibrium between the Z and E isomer forms in polar solvents such as DMSO or 
methanol, or in the presence of light.
81 
 The design feature of incorporating the 2,6-difluorobenzyl moiety exhibited in 
compounds 76 and 98 was based on a structural resemblance to the “warhead” of the protease 
inhibitor Q-VD-OPh
55 
which possibly forms covalent interactions with the cysteine residue of a 
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caspase enzyme due to its electrophilic nature. Although compound 76 was found ineffective as 
a cell death inhibitor, it was thought that the N-alkylation of this substrate using benzyl chloride 
might result in an enhancement in inhibitory properties since N-alkylation of isatin sulfonamides 
usually led to approximately ten fold increase in activity. Thus, compound 76 was refluxed in 
acetonitrile using KF/alumina base for 12 h. The reaction produced an orange oil which was then 
triturated with several milliliters of methanol to yield orange crystals of 111 in 39% yield. 
N O
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1. KF/Al2O3
2. Benzyl Chloride
    ACN, 12 h
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In an effort to utilize the activity of 3-((pyridine-4-yl)methylene)indolin-2-one (78), and 
its positional isomers 105 and 106, as well as possibly increase the potency of the benzylidene 
derivatives, the N-alkylation of compound 78 was attained using 2,6-difluorobenzyl bromide.  
The reaction was allowed to reflux in acetonitrile using KF/alumina base for up to 5 days while 
being monitored by TLC analysis periodically. However, despite this prolonged reaction time the 
desired compound 113 was not isolated. The next step was to attempt the isolation of the 
compound where by the aldol condensation reaction would be done in the last step. 
Given the demonstrated activity exhibited by 3-(4-methoxybenzylidene)indolin-2-one, it 
was thought likely that introduction of the difluorophenyl moiety on this substrate would result 
in enhanced activity. Thus, compound 98 was used to form 1-(2,6-difluorobenzyl)-3-(4-
111 76 
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methoxybenzylidene)indolin-2-one (112) by way of Knoevenagel condensation with p-
anisaldehyde as shown below. As described earlier, this molecule incorporates seemingly 
important features such as a hydrogen bond acceptor motif at the C-3 position due to the para-
methoxy group, along with the difluorophenyl pattern exhibited by Q-VD-OPh.
65 
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Although it was not possible to N-alkylate 3-((pyridine-4-yl)methylene)indolin-2-one 
(78) with 2,6-difluorobenzyl bromide, the synthesis of the desired target compound could be 
achieved by condensing 98 with 4-pyridinecarboxaldehyde, using 0.1 equiv. piperidine as a 
catalyst for 20 h yielding 113 in 53% yield.  
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    EtOH, 90ºC, 20 h
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Biological Activity 
From the outset, the unexpected inhibitory activity exhibited against Jurkat T cells in 
vitro by the 3-((pyridine-4-yl)methylene)indolin-2-one (78)
77
 wherein no electron withdrawing 
substituent was necessary at the C-5 position warranted an examination of the positional isomers, 
namely compounds 105 and 106. The 4-pyridine compound showed complete inhibition of 
apoptosis at 50 μM and only partial inhibition at 20 μM concentrations. Compounds 105 and 106 
were prepared as described and sent to Dr. Thomas L. Brown at the Wright State University 
Department of Neuroscience, Cell Biology, and Physiology for biological screening. The 
biological assay was performed to verify if indeed the compounds being tested could inhibit 
apoptotic cell death. The tests conducted were blind tests, meaning that the researchers doing the 
screening were prevented from knowing the identities of the compounds. The screening was also 
performed by different people at different times to give consistent results. The gels for 
compounds 106 and 105 are shown in Figure 14 and Figure 15, respectively. 
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Figure 14: DNA laddering for Compound 106 
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Figure 15: DNA laddering for Compound 105 
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50µM- 10μl CMC-II-8 & 10μl AD 
100µM- 20μl CMC-II-8 & 10μl AD 
 
 The “M” channel is the DNA marker channel, which shows the DNA laddering of 180-
200 base-pair DNA fragments being tested. The “V” channel contains DMSO and methanol 
solvent and the cells being tested only. The “AD” channel contains cells that are treated with the 
Actinomycin D protein, which is a DNA dependent inhibitor of RNA synthesis and acts as a 
cytotoxic inducer of apoptosis. The channels that are marked with 20, 50 and 100 are the 
micromolar concentrations of the compound being tested and the assays were treated for four 
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hours. In each example the disappearance of the dark laddering at 100 μM translates to activity, 
which means that apoptosis was prevented in the Human Jurkat T cells (Type 2 cells) at 100 µM 
concentrations of the compound. Based on the results it was hypothesized that the lone pair of 
electrons on the nitrogen atom of the benzylidene ring is involved in hydrogen bonding with the 
active site of the caspase and also resembles the quinoline ring of the known peptide inhibitor Q-
VD-OPh.
56
 
 As discussed earlier, the idea for synthesizing compound 112 was based on the fact that 
3-(4-methoxybenzylidene)indolin-2-one (77) was previously found to be active against Jurkat T 
cells at approximately 50 μM. It was hypothesized that incorporating the 2,6-difluoro moiety at 
the nitrogen would possibly increase the potency versus the Actinomycin D induced apoptotic 
cells. Unfortunately, 112 tested inactive against the Jurkat T cell assay, and the addition of the 
2,6-difluorobenzyl group appeared to weaken the affinity of the para-methoxybenzylidene 
compound for the active site. 
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Likewise, given the demonstrated activity of 3-((pyridine-4-yl)methylene)indolin-2-one 
(78), it was deemed important to examine the inhibitory properties of the analog possessing the 
biologically relevant 2,6-difluorophenyl moiety. The appropriately designed derivative (e.g., 
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113) was therefore prepared and sent to Dr. Brown for biological screening and it was found to 
inhibit the cell death of 100% of Jurkat T cells at 20 μM (as shown in Figure 16) and was further 
evaluated and found to be partially active at 10 μM (laddering analysis not shown).   
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Figure 16: DNA laddering for Compound 113 
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20µM- 4μl DK Chem CMC-I-188 & 10μl AD 
50µM- 10μl CMC-I-188 & 10μl AD 
100µM- 20μl CMC-I-188 & 10μl AD 
 
The cell death inhibitory properties of compound 113 as evidenced from the gel above 
were interesting in that this was the first oxindole derived inhibitor with two points of variability 
to exhibit substantial biological activity against Jurkat T cells. To compare and understand 
further how diverse functional groups extended from the isatin/oxindole scaffold work together 
to maximize binding affinity to caspases, an electron withdrawing group was needed at the C-5 
position of 113. Thus compound 115 was synthesized by Paul Repasky (colleague) by way of 
refluxing 1-(2,6-difluorobenzyl)-5-chloroindolin-2-one (114) with 4-pyridincarboxaldehyde in 
ethanol. Biological screening of compound 115 against Jurkat T cells showed that compound 115 
possessed 90% inhibition of cell death at 10 μM.   
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Even though the results for compound 115 only showed an approximately 70-90% 
increase of inhibition compared to compound 113, this was a remarkable finding. Adding an 
additional point of functionality to the isatin/oxindole core provided the ability to create a larger 
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library of compounds that would aid in the quest to find a potent caspase inhibitor for drug 
discovery.  Not only was this true, but the “3-points of variability” idea was first introduced by 
Dr. Ketcha‟s group at Wright State University and seems to have led to the preparation of 
increased potency of a small molecule like caspase inhibitor. 
 
Summary and Conclusion 
 Initially, small scale microwave irradiation reactions were performed to probe for 
optimum parameters in order to acquire 100% completion for the generation of N-alkylated isatin 
derivatives. Ultimately these reactions were employed via conventional heating in the first step 
of a sequence designed to create a diverse library of compounds possessing the characteristics of 
the peptide inhibitor Q-VD-OPh as well as features common to the analogous isatin sulfonamide 
inhibitors. Furthermore, the Wolff-Kishner and aldol condensation reactions were employed in 
addition to N-alkylation reactions to ultimately synthesize targeted tri-substituted compounds. 
The ultimate targets, namely oxindole benzylidene compounds possessing up to 3-points of 
variability were then screened for biological activity against Jurkat T cells. Thorough NMR 
analysis was performed on the N-alkylated products as well as all of the compounds presented in 
this study to understand the electronic effects of substituents attached to the isatin/oxindole 
scaffold and how the NMR analysis results of both active and non-active compounds could 
possibly be used to assess and direct the synthesis of targeted compounds to enhance inhibition 
activity.  
 In previous years, H. Abdallah showed that the 4-pyridyl analog 78 was active against 
Jurkat T cells at 50 μM presumably via hydrogen bonding interactions within an unknown 
 
80 
 
enzyme subsite. The present study sought to enhance the inhibition activity of the 4-pyridyl 
benzylidene oxindoles by adding a 2,6-difluorobenzyl group at the nitrogen. In this study, further 
steps were taken to assess the position of the nitrogen atom about the pyridine ring which led to 
the 2-pyridine and 3-pyridine moieties, 105 and 106, respectively, which were both screened 
against Jurkat T cells for comparison to the known inhibitory effects of the 4-pyridine lead 78, 
which in the end proved to be the most potent compound amongst the three positional isomers. 
Due to this fact, the next important objective was to perform an N-substitution reaction on the 4-
pyridine benzylidene for which the resultant product 113 was desired to possibly show enhanced 
inhibition concentrations against Jurkat T cells. Based on the DNA laddering gel results, the 
potency of the former compound was indeed increased by approximately 2.5-fold but still only 
exhibited 2-points of variability. A third point of functionality of the former compound was 
utilized at the C-5 position about the oxindole core, incorporating a chlorine atom, which is 
important due to its electron-withdrawing ability and anticipated metabolic stability, to 
ultimately generate the desired tri-substituted analog, 115, showing a nearly 2-fold increase in 
potency versus the “2-point” derivative. Unfortunately, there were no mechanistic or toxicity 
studies performed and it is not currently known exactly how the former active compounds bind 
within an enzyme sub-site. However, in this report, the importance of isatin and oxindole 
derivatives ranging from mono-substituted (i.e., 3-substituted benzylidene compounds) to tri-
substituted compounds was demonstrated to possess novel pro-apoptotic properties as potentially 
useful therapeutic agents. Moreover, the compounds generated in this report, along with 
composed analytical data, and correlating biological findings are significant to the advancement 
of this research and its entirety can be utilized as a “stepping stone” for the continuing efforts 
and discovery of small molecular based cell death inhibitors. 
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Future Work 
 In the near future a library of molecules should be created that will be further utilized and 
assessed for biological activity not only towards Jurkat T cells, but other lines of cells to assess 
the known and anticipated activity of these simple heterocyclic molecules. The next generation 
of these molecules should provide four or more points of variability which will allow for a larger 
quantitative molecular library which will provide more opportunities for fine tuning and 
designing molecular species to achieve their highest potential as caspase inhibitors.  
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Experimental 
Chemical Analysis 
Melting points were determined via the use of open capillaries with an Electrothermal 
melting point apparatus and are reported uncorrected. Elemental analyses were performed by 
Midwest Microlab, Indianapolis, IN. Elemental analysis results are within +0.4% of the 
theoretical values. The 
1
H and 
13
C NMR data were obtained on a Bruker Avance 300 MHz NMR 
in CDCl3 solution unless otherwise indicated.  The chemical shifts are reported in δ (ppm) 
downfield from tetramethylsilane as an internal standard;coupling constants (J) are in Hz. The 
following abbreviations are used to describe peak patterns where appropriate: s, singlet; d, 
doublet, dd, double doublet; t, triplet; q, quartet; dt, double triplet; m, multiplet. GC/MS 
measurements were performed using Hewlett-Packard 6890 Series GC with auto injection and 
mass fragments are reported as mass per charge, m/z. The GC was coupled with a mass 
spectrometer with a Hewlett-Packard 5973 mass selective detector/quadrupole system. Flash 
column (Silica Gel, Premium Rf, 200-400 mesh, Sorbent Technologies) and thin layer 
chromatography (TLC) wereperformed on silica gel with indicated solvent systems. All 
microwave reactions wereperformed in a monomode Biotage Emery‟s Creator 300 Watt system 
and the MARS Glasschem 300 Watt system by CEM. It should be noted that all reactions were 
run with sample absorption set to “normal”. 
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5-Nitroindoline-2,3-dione (33) 
To a 50 mL Erlenmeyer flask in an ice bath, was added  a solution of isatin (6.86 mmol, 1.01 g) 
in concentrated H2SO4 (6.4 mL) dropwise to a solution of KNO3 (6.80 mmol, 0.688 g) in 
concentrated H2SO4 (7.6 mL) over a period of 1h. The reaction mixture was allowed to stir for 
30 min. and then poured over ice. An orange solid was collected by vacuum filtration. The 
product was then recrystallized from ethanol to give an orange solid (1.06 g, 81%); mp 249-
254ºC, (lit.
12
mp 252-254ºC); Rf = 0.23 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz DMSO-d6)  
11.66 ppm (s, N-H), 8.44 (dd, J = 8.64, 1.71Hz, 1H), 8.20 (s, J = 2.01Hz, 1H), 7.09 (d, J = 
8.67Hz, 1H); 
13
C NMR δ: 182.3, 159.8, 155.2, 142.6, 133.1, 119.5, 118.0, 112.5; MS (m/z):192 
(M
+
), 164 (100%). 
(Z)-3-(2,6-Difluorobenzylidene)-5-nitro-indolin-2-one (75) 
To a vial was added 5-nitro-indolin-2-one (1.133 mmol, 0.2018 g) with 2,6-
difluorobenzaldehyde (1.2 equiv., 1.36 mmol, 0.1932 g, 0.147 mL), piperidine (0.1359 mmol, 
0.0097 g, 0.0112 mL) and EtOH (12 mL). The vial was placed on a hot plate at 90ºC for 2h 
while stirring. A light green precipitate (0.1647 g, 48%) was collected by vacuum filtration: mp 
257-258ºC; (lit.
77
mp 251-255ºC); Rf = 0.73 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, DMSO-
d6) δ 11.45 (s, N-H), 8.22 (d, J = 8.67Hz, 1H), 7.75-7.65 (m, 3H), 7.58 (s, Hvinyl), 7.37 (t, J = 
8.31Hz, 1H), 7.08 (d, J = 8.58Hz, 1H); 
13
C NMR δ: 167.8, 161.3, 157.9, 148.9, 141.9, 133.0, 
130.2, 127.2, 123.3, 120.9, 118.3, 112.3, 111.3, 110.3 ppm; MS (m/z): 302 (M
+
, 100%). 
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(Z)-3-(2,6-Difluorobenzylidene)indolin-2-one (76) 
To a 50 mL erlenmeyer flask was added oxindole (7.510 mmol, 1.00 g) with 2,6-
difluorobenzaldehyde (1.2 equivalents, 9.01 mmol, 0.9725 mL), piperidine (0.1 equivalents, 
0.7510 mmol, 0.0743 mL) and EtOH (25 mL). The flask was placed on a hot plate at 90˚C for 3 
h while stirring. A yellow precipitate was collected by vacuum filtration and then (1.3309 g, 
69%): mp 233-238˚C, (lit.
77
mp 213-218ºC); Rf = 0.37 (EtOAc/hexanes, 1:1); 
1
H NMR (300 
MHz, DMSO-d6) 10.72 (s, N-H), 7.65-7.55 (m, 3H), 7.35 (s, Hvinyl), 7.29 (t, J = 8.46Hz, 1H), 
6.88 (d, J = 8.13Hz, 1H); 
13
C NMR δ: 167.5, 161.3, 158.0, 143.2, 132.3, 132.0, 130.8, 123.1, 
121.5, 120.7, 119.7, 112.1, 112.0, 110.1 ppm; MS (m/z): 257 (M
+
, 100%). 
1-Benzylindoline-2,3-dione (80) 
To a solution of isatin (7.08 mmol, 1.042 g) in acetonitrile (70 mL), was added 15 equiv. of 
KF/alumina (42.3 mmol, 6.47 g) and the resulting mixture was allowed to stir for 5 min until the 
initial orange solution turned to a brownish color. Benzyl chloride (1.5 equiv., 10.62 mmol, 1.22 
mL) was then added dropwise to the stirred solution after which time the mixture was then 
refluxed under acetonitrile for 2 h. The mixture was then allowed to cool to rt and the suspended 
KF/alumina was vacuum filtered from the solution. The filtrate was then evaporated under 
reduced pressure to afford a solid which was recrystallized from DCM/hexanes to afford the pure 
(TLC, GC/MS) product as orange crystals (1.47 g, 81%): mp 130-132˚C; (lit.
68
mp 126-127ºC); 
Rf  = 0.4 (EtOAc/Hexanes, 1:1); 
1
H NMR (300 MHz CDCl3)  7.62 ppm (dd, J = 7.2Hz, 0.75Hz, 
1H), 7.5 (td, J = 7.83Hz, 1.32Hz, 1H) 7.41-7.3 (m, 5 × Ar-H), 7.10 (td, J = 7.53Hz, 0.75Hz, 1H), 
6.8 (d, J = 7.92Hz, 1H), 4.95 (s, 1H); 
13
C NMR δ: 183.2, 158.3, 150.7, 138.3, 134.5, 129.1, 
128.2, 127.4, 125.4, 123.8, 117.7, 111.0, 44.1 ppm; MS (m/z): 237 (M
+
), 146 (100%). 
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Ethyl 2-(2,3-dioxoindolin-1-yl)acetate (81) 
To a solution of isatin (3.4 mmol, 0.503 g) in acetonitrile (35 mL), was added KF/alumina (20.39 
mmol, 3.201 g) and the resulting mixture was allowed to stir for 5 min until the initial orange 
solution turned to a brownish color. Ethyl bromoacetate (1.5 equiv., 5.09 mmol, 5.28 g, 0.567 
mL) was pipetted into the round bottom flask after which the time the mixture was then refluxed 
under acetonitrile for 21 h. The mixture was then allowed to cool to rt and the suspended 
KF/alumina was vacuum filtered from the solution. The filtrate was then allowed to dry under 
the fume hood overnight to afford the pure (TLC, GC/MS) yellow solid product (0.77 g, 97%): 
mp 124-129˚C; (lit.
68
mp 132-133ºC); Rf = 0.51 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz 
CDCl3)  7.64 ppm (dd, J = 7.56Hz, 0.75Hz, 1H), 7.6 (td, J = 7.83Hz, 1.35Hz, 1H), 7.16 (td, J = 
7.54Hz, 0.72Hz, 1H), 6.81 (d, J = 7.98Hz, 1H), 4.49 (s, 2H), 4.25 (q, J = 7.15Hz, 2H), 1.29 (t, J 
= 7.08Hz, 3H); 
13
C NMR (300 MHz DMSO-d6) δ: 182.6, 167.3, 158.2, 150.3, 138.5, 124.5, 
123.7, 117.2, 111.2, 61.3, 41.2, 14.0 ppm; MS (m/z): 233 (M
+
), 132 (100%). 
1-(2,6-Dichlorobenzyl)indoline-2,3-dione (82) 
To a solution of isatin (3.39 mmol, 0.5 g) in acetonitrile (115 mL), was added KF/alumina (20.4 
mmol, 3.12 g) and the resulting mixture was allowed to stir for 5 min until the initial orange 
solution turned to a brownish color. Then 2,6-dichlorobenzyl bromide (1.5 equiv., 5.1 mmol, 
1.22 g) was added to the round bottom flask after which time the mixture was then refluxed 
under acetonitrile for 8 h. The mixture was then allowed to cool to rt and the suspended 
KF/alumina was vacuum filtered from the solution. The filtrate was then evaporated under  
reduced pressure to afford a solid which was recrystallized from chloroform/hexanes to afford 
the pure (TLC, GC/MS) product as orange crystals (3.04 g, 66%): mp 175-180˚C; Rf = 0.73 
 
86 
 
(EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz CDCl3)  7.61 ppm (dd, J = 7.47Hz, 0.75Hz, 1H), 
7.46 (td, J = 7.83Hz, 1.35Hz, 1H), 7.39 (d, J = 8.31Hz, 1H), 7.28 (d, J = 7.23Hz, 1H), 7.26 (t, J = 
6.51Hz, 1H), 7.08 (t, J = 7.56Hz, 1H), 6.75 (d, J = 7.89Hz, 1H), 5.26 (s, 2H); 
13
C NMR δ: 182.9, 
157.7, 150.4, 138.4, 136.4, 130.3, 129.2, 129.1, 125.3, 123.6, 117.9, 111.1, 40.3 ppm; MS (m/z): 
305 (M
+
), 270 (100%); Anal. Calcd for C15H9Cl3NO2: C, 58.85; H, 2.96; N, 4.58 Found: C, 
58.77; H, 3.04; N, 4.57. 
1-(2,6-Difluorobenzyl)indoline-2,3-dione
35
 (83) 
To a solution of isatin (6.84 mmol, 1.01 g) in acetonitrile (70 mL), was added 15 equiv. of 
KF/alumina (40.7 mmol, 6.40 g) and the resulting mixture was allowed to stir for 5 min until the 
initial orange solution turned to a brownish color. Then 2,6-difluorobenzyl bromide (1.5 equiv., 
10.2 mmol, 2.11 g) was added to the round bottom flask after which time the mixture was then 
refluxed under acetonitrile for 20.5 h. The mixture was then allowed to cool to rt and the 
suspended KF/alumina was vacuum filtered from the solution. The filtrate was then evaporated 
under reduced pressure to afford a solid which was recrystallized from DCM/hexanes to afford 
the pure (TLC, GC/MS) product as brown crystals (1.64 g, 88%): mp 154-156˚C; Rf = 0.46 
(EtOAc/hexanes, 1:1);
 1
H NMR (300 MHz CDCl3)  7.60 ppm (dd, J = 7.47Hz, 0.75Hz, 1H), 
7.53 (t, J = 7.83Hz, 1H), 7.32 (m, 1H), 7.10 (t, J = 7.52Hz, 1H), 6.94 (t, J = 8.22Hz, 1H), 5.03 (s, 
1H); 
13
C NMR δ: 182.9, 163.2, 159.9, 157.5, 150.4, 138.4, 130.5, 125.3, 123.8, 117. 7, 111.8, 
110.3, 110.3, 32.2 ppm; MS (m/z): 273 (M
+
, 100%); (This is a known compound as referenced in 
literature above, however there were no physical properties reported). 
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3-(2,3-Dioxoindolin-1-yl)propanoic acid (85) 
To a solution of isatin (2.500 mmol, 0.3678 g) in acetonitrile (30 mL), was added KF/alumina 
(19.0  mmol, 2.91 g) and the resulting mixture was allowed to stir for 10 minutes until the initial 
orange solution turned to a dark brownish color, inside a 250 mL round bottom flask. Tert-butyl 
acrylate (3.0 equiv., 7.50 mmol, 0.961g, 1.089 mL) was then added to the stirred solution after 
which time the mixture was then refluxed under acetonitrile for 1.5h. The mixture was then 
allowed to cool to rt and the suspended KF/alumina was vacuum filtered from the solution, to 
give a impure red oil. A silica gel column (hexanes/EtOAc, 70:30) was used to purify separate 
the product from impurities to give a red solid. The solid was then recrystallized from 2-propanol 
to afford pure (TLC) product as red crystals (0.1256 g, 18%): mp 144-149ºC; Rf = 0.53 
(EtOAc/hexanes, 1:1)
 1
H NMR (300 MHz DMSO-d6)  12.41 ppm (s, 1H), 7.66 (d, J = 7.76Hz, 
1H), 7.54 (d, J = 7.32Hz, 1H), 7.24 (d, J = 7.89Hz, 1H), 7.12 (t, J = 7.47Hz, 1H), 3.89 (t, J = 
7.28Hz, 2H), 2.62 (t, J = 7.19Hz, 2H); 
13
C NMR δ: 183.4, 172.2, 158.0, 150.4, 138.1, 124.4, 
123.1, 117.5, 110.9, 35.6, 31.4 ppm; Anal. Calcd for C11H9NO4: C, 60.27; H, 4.14; N, 6.39  
Found: C, 60.34; H, 4.36; N, 6.30. 
1-Benzyl-5-chloroindoline-2,3-dione
40
 (88) 
To a solution of 5-chloroisatin (5.51 mmol, 1.00 g) in acetonitrile (70 mL), was added 
KF/alumina (33.04 mmol, 5.19 g) and the resulting mixture was allowed to stir for 10 min until 
the initial orange solution turned to a dark brownish color. Benzyl chloride (1.5 equiv., 8.26 
mmol, 0.952 mL) was then added dropwise to the stirred solution after which time the mixture 
was then refluxed under acetonitrile for 47 h. The mixture was then allowed to cool to rt and the 
suspended KF/alumina was vacuum filtered from the solution. The filtrate was then evaporated 
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under reduced pressure to afford a solid which was recrystallized from ethanol to afford the pure 
(TLC, GC/MS) product as orange crystals (1.20 g, 65%): mp 134˚C; Rf = 0.65 (EtOAc/hexanes, 
1:1)
 1
H NMR (300 MHz CDCl3)  7.57 ppm (d, J = 2.22Hz, 1H), 7.45 (dd, J = 8.43Hz, 2.2Hz, 
1H), 7.37-7.31 (m, 5 × Ar-H), 6.75 (d, J = 8.34Hz, 1H), 4.94 (s, 2H); 
13
C NMR δ: 182.2, 157.7, 
149.0, 137.7, 134.2, 129.7, 129.2, 128.4, 127.4, 125.3, 118.6, 112.3, 44.1 ppm; MS (m/z): 271 
(M
+
), 180 (100%). (This is a known compound as referenced in literature above, however there 
were no physical properties reported). 
Ethyl 2-(5-chloro-2,3-dioxoindolin-1-yl)acetate
37
 (89) 
To a solution of 5-chloroisatin (2.76 mmol, 0.501 g) in acetonitrile (35 mL), was added 
KF/alumina (16.5 mmol, 2.61 g) and the resulting mixture was allowed to stir for 10 min until 
the initial orange solution turned to a dark brownish color. Ethyl bromoacetate (1.5 equiv., 4.13 
mmol, 0.734 mL) was pipette into the reaction mixture, and then refluxed under acetonitrile for 9 
h. The mixture was then allowed to cool to rt and the suspended KF/alumina was vacuum filtered 
from the solution. The filtrate was then allowed to dry under the fume hood overnight to afford 
the pure (TLC, GC/MS) yellow solid (0.64 g, 87%): mp 130-135˚C; Rf = 0.68 (EtOAc/hexanes, 
1:1); 
1
H NMR (300 MHz DMSO-d6)  7.75 ppm (dd, J = 8.55Hz, 2.22Hz, 1H), 7.67 (d, J = 
2.01Hz, 1H), 7.25 (d, J = 8.46Hz, 1H), 4.63 (s, 2H), 4.17 (q, 7.08Hz, 2H), 1.22 (t, J = 7.13Hz, 
3H); 
13
C NMR δ: 181.5, 167.3, 157.8, 148.9, 137.4, 127.9, 124.1, 118.6, 112.9, 61.4, 41.3, 14.0; 
MS (m/z): 267 (M
+
), 166 (100%). (This is a known compound as referenced in literature above, 
however there were no physical properties reported). 
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1-(2,6-Dichlorobenzyl)-5-chloroindoline-2,3-dione (90) 
To a solution of 5-chloroisatin (2.78 mmol, 0.504 g) in acetonitrile (35 mL), was added 
KF/alumina (16.4 mmol, 2.50 g) and the resulting mixture was allowed to stir for 10 min until 
the initial orange solution turned to a dark brownish color. Then 2,6-dichlorobenzyl bromide (1.5 
equiv., 4.16 mmol, 0.99 g) was added to the round bottom flask and then refluxed under 
acetonitrile for 24 h. The mixture was then allowed to cool to rt and the suspended KF/alumina 
was vacuum filtered from the solution. The filtrate was then allowed to dry under the fume hood 
for several days to afford the pure (TLC, GC/MS) orange solid (20.55g, 58%): mp 233-235˚C; Rf 
= 0.67 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz DMSO-d6)  7.71 ppm (dd, J = 8.49Hz, 
2.30Hz, 1H), 7.66 (d, J = 2.31Hz, 1H), 7.54 (d, J = 8.01Hz, 1H), 7.42 (t, 7.92Hz, 1H), 7.00 (d, J 
= 8.37Hz, 1H), 5.13 (s, 2H); 
13
C NMR δ: 181.7, 157.5, 149.2, 137.3, 135.4, 130.8, 129.5, 129.1, 
127.7, 124.2, 119.0, 112.6, 40.4; MS (m/z): 339 (M
+
), 180 (100%); Anal. Calcd for 
C15H8Cl3NO2:  C, 52.90; H, 2.37; N, 4.11 Found: C, 52.76; H, 2.46; N, 4.07. 
1-(2,6-Difluorobenzyl)-5-chloroindoline-2,3-dione
35
 (91) 
To a solution of 5-chloroisatin (2.76 mmol, 0.502 g) in acetonitrile (35 mL), was added 
KF/alumina (17 mmol, 2.6 g) and the resulting mixture was allowed to stir for 10 min until the 
initial orange solution turned to a dark brownish color, inside a 250 mL round bottom. Then 2,6-
difluorobenzyl bromide (1.5 equiv., 4.15 mmol, 0.85 g) was added to the round bottom flask and 
then refluxed under acetonitrile for 24 h. The mixture was then allowed to cool to rt and the 
suspended KF/alumina was vacuum filtered from the solution. The filtrate was then evaporated 
under reduced pressure to afford a solid which was recrystallized from DCM/hexanes to afford 
the pure (TLC, GC/MS) product as reddish-violet crystals (0.76 g, 89%): mp 172-177˚C; Rf = 
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0.46 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz CDCl3)  7.57 ppm (d, J = 2.07Hz, 1H), 7.50 
(dd, J = 8.25Hz, 2.27Hz, 1H), 7.39-7.28 (m, 1H), 6.96 (t, J = 8.15Hz, 1H), 6.75 (d, 8.55Hz, 1H), 
4.94 (s, 2H); 
13
C NMR δ: 181.8, 163.2, 159.7, 156.9, 148.5, 137.8, 130.8, 129.7, 125.2, 118.6, 
111.9, 111.6, 109.9, 32.4; MS (m/z): 307 (M
+
, 100%). (This is a known compound as referenced 
in literature above, however there were no physical properties reported). 
5-Nitroindolin-2-one (95) 
To a 25-mL Erlenmeyer flask in an ice bath containing sulfuric acid (3.84 mL) and oxindole 
(7.54 mmol, 1.0042 g) was added  nitric acid (0.323 mL) dropwise with stirring. The mixture 
was stirred for 30 min after which the mixture was poured over ice. A brown colored solid 
(0.6030 g) was collected via vacuum filtration. Recrystallization using 50% acetic acid/water 
gave the pure product (brown color) (0.3125 g, 23%); mp 240-243
o
C, (lit.
82
mp 240-241
o
C); Rf = 
0.28 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, DMSO-d6) 11.03 (s, N-H), 8.13 (d, J = 8.4 
Hz, 1H), 8.07 (s, 1H), 6.97 (d, J = 8.4 Hz, 1H), 3.62 (s, 2H); 
13
C NMR : 176.7, 150.3, 141.7, 
127.1, 125.0, 119.9, 108.9, 35.5 ppm; MS (m/z): 178 (M
+
, 100%). 
1-(2,6-Difluorobenzyl)indolin-2-one (98) 
To a 250 mL round bottom flask was added 1-(2,6-difluorobenzyl)indoline-2,3-dione (7.32 
mmol, 2.0 g) with 80%/wt hydrazine-hydrate (45 mL). The round bottom flask was covered with 
aluminum foil and then allowed to stir under reflux for 4h. The reaction mixture was allowed to 
cool to room temperature and then distilled water (80 mL) was added with 6N HCl (60 mL) to 
the flask. The reaction mixture was then extracted into EtOAc (75 mL) and the organic layer was 
washed with brine 3-times and dried with NaSO4. The organic layer was then evaporated under 
the reduced pressure to afford the pure (GC/MS, TLC) tan solid (1.801 g, 95%): mp 157-162ºC; 
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Rf = 0.41 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, CDCl3) m, 3H), 6.91 (t, J = 
7.52Hz, 1H), 6.82 (d, J = 8.07Hz, 1H), 6.76 (t, J = 7.32Hz, 1H), 4.93 (s, 2H), 3.48 (s, 2H); 
13
C 
NMR δ: 174.3, 163.3, 160.0, 143.7, 129.9, 127.9, 124.4, 124.4, 122.3, 111.6, 111.5, 108.4, 35.6, 
32.0 ppm; MS (m/z): 259 (M
+
, 100%); Anal. Calcd for C15H11F2NO:  C, 69.49; H, 4.28; N, 5.40  
Found: C, 68.58; H, 4.45; N, 5.66. 
1-Benzyl-5-chloroindolin-2-one (99) 
To a 250 mL round bottom flask was added 1-benzyl-5-chloroindoline-2,3-dione (3.68 mmol, 
1.00 g) with 80%/wt hydrazine-hydrate (25 mL). The round bottom flask was covered with 
aluminum foil and then allowed to stir under reflux for 5h. The reaction mixture was allowed to 
cool to room temperature and then distilled water (20 mL) was added with 6N HCl (40 mL) to 
the flask. The reaction mixture was then extracted into EtOAc (50 mL) and the organic layer was 
washed with brine 3-times and dried with NaSO4. The organic layer was then evaporated under 
reduced pressure to afford the pure (GC/MS, TLC) tan solid, which was recrystallized from 
DCM/hexanes to give a tan solid (0.7224 g, 76%): mp 103-105ºC; (lit.
83
mp 103-105ºC); Rf = 
0.38 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, CDCl3) m, 3H), 6.91 (t, J = 
7.52Hz, 1H), 6.82 (d, J = 8.07Hz, 1H), 6.76 (t, J = 7.32Hz, 1H), 4.93 (s, 2H), 3.48 (s, 2H); 
13
C 
NMR δ: 174.3, 163.3, 160.0, 143.7, 129.9, 127.9, 124.4, 124.4, 122.3, 111.6, 111.5, 108.4, 35.6, 
32.0 ppm; MS (m/z): 257 (M
+
), 91 (100%). 
(Z)-3-(4-Nitrobenzylidene)indolin-2-one (103) 
To a vial was added oxindole (1.877 mmol, 0.2500 g) with 4-nitrobenzaldehyde (1.2 equiv., 
2.253 mmol, 0.3405 g), piperidine (0.1 equivalents, 0.1877 mmol, 0.0159 g, 0.01856 mL) and 
EtOH (8 mL). The vial was placed on a hot plate at 90˚C for 3 h while stirring. The heat was 
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then turned off and the mixture was allowed to continue stirring for 24 h. An orange precipitate 
formed (0.4109 g, 81%) and was collected by vacuum filtration: mp 251-252˚C, (lit.
73
mp 245-
250ºC); 
1
H NMR (300 MHz, DMSO-d6) 10.68 (s, N-H), 8.33 (d, J = 8.37 Hz, 1H), 7.93 (d, J = 
8.37Hz, 1H), 7.65 (s, Hvinyl), 7.39 (d, J = 7.59Hz, 1H), 7.25 (t, J = 7.49Hz, 1H), 6.87 (m, 2H); 
13
C NMR : 168.1, 147.4, 143.4, 141.4, 132.8, 131.0, 130.4, 130.0, 123.9, 122.8, 121.3, 120.2, 
110.3 ppm; MS (m/z): 266 (M
+
, 100%). 
(E/Z)-3-(3-Nitrobenzylidene)indolin-2-one (104) 
To a vial was added oxindole (1.877 mmol, 0.2500 g) with 3-nitrobenzaldehyde (1.2 equivalents, 
2.253 mmol, 0.3405 g) piperidine (0.1 equivalents, 0.1877 mmol, 0.0159 g, 0.01856 mL) and 
EtOH (8 mL). The vial was placed on a hot plate at 90˚C for 3 h while stirring. A yellow 
precipitate formed (0.4486 g, 90%) and was collected by vacuum filtration: mp 244-246˚C, 
(lit.
74
mp 258ºC); 
1
H NMR (300 MHz, DMSO-d6) 10.71 (s, N-H), 10.67(s, N-H), 9.37 (s, 1H), 
8.62 (d, J = 7.68Hz, 1H), 8.50 (s, 1H), 8.27 (t, J = 9.33Hz, 1H), 8.11 (d, J = 7.44Hz, H2,6), 7.92 
(s, 1H), 7.79 (t, J =8.01Hz, 1H) 7.72 (d, J = 8.01Hz, H2,6), 7.67 (s, Hvinyl), 7.40 (d, J = 7.62Hz, 
1H), 7.25 (t, J = 7.61Hz, 1H) 7.00 (t, J = 7.61Hz, 1H), 6.90-6.81 (m, 1H); 
13
C NMR : 168.2, 
166.9, 147.9, 147.6, 143.4, 141.3, 137.8, 136.2, 135.5, 135.3, 133.7, 132.8, 130.8, 130.3, 129.7, 
129.5, 129.1, 125.8, 124.3, 123.9, 123.5, 122.5, 121.3, 120.3, 110.3, 109.6 ppm; MS (m/z): 266 
(M
+
, 100%). 
 (Z)-3-((Pyridine-2-yl)methylene)indolin-2-one (105) 
To a vial was added oxindole (3.76 mmol, 0.50 g) with 2-pyridinecarboxaldehyde (1.2 
equivalents, 4.51 mmol, 0.483 g, 0.428 mL) piperidine (0.1 equivalents, 0.451 mmol, 0.0384 g, 
0.0446 mL) and EtOH (8 mL). The vial was placed on a hot plate at 90˚C for 6 h while stirring. 
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A yellow precipitate (0.6287 g, 75%) was collected by vacuum filtration: mp 206-209˚C, 
(lit.
75
mp 202-203ºC); Rf  = 0.075 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, DMSO-d6) 10.64 
(s, N-H), 9.02 (d, J = 7.77Hz, 1H), 7.96 (t, J = 7.59Hz, 1H), 7.88 (d, J = 7.5Hz, 1H), 7.60 (s, 
Hvinyl), 7.48 (t, J = 5.96Hz, 1H), 7.30 (t, J = 7.67Hz, 1H), 7.00 (t, J = 7.68Hz, 1H), 6.89 (d,  J = 
7.74Hz, 1H); 
13
C NMR : 169.2, 153.2, 149.6, 143.6, 137.2, 133.6, 130.8, 129.2, 128.4, 127.9, 
124.1, 121.2, 109.6 ppm; MS (m/z): 221 (M
+
, 100%). 
(E/Z)-3-((Pyridine-3-yl)methylene)indolin-2-one
84
 (106) 
To a vial was added oxindole (3.76 mmol, 0.50 g) with 3-pyridinecarboxaldehyde (1.2 
equivalents, 4.51 mmol, 0.483 g, 0.423 mL) piperidine (0.1 equivalents, 0.451 mmol, 0.0384 g, 
0.0446 mL) and EtOH (8 mL).  The vial was placed on a hot plate at 90˚C for 5 h while stirring. 
A yellow precipitate (0.3032 g, 36%) was collected by vacuum filtration: mp 161-165˚C; Rf  = 
0.043 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, DMSO-d6) 10.67 (s, N-H), 9.20 (s, N-H), 
8.88 (t, J = 9.59Hz, 1H), 8.66 (d, J = 4.74Hz, 1H), 8.59 (d, J = 4.71Hz, 1H), 8.12 (d, J = 7.83Hz, 
1H), 7.83 (s, 1H), 7.73 (d, J = 7.44Hz, 1H), 7.64 (s, 1H), 7.59-7.47 (m, 1H), 7.39 (d, J = 7.83Hz, 
1H), 7.26 (t, J = 7.65Hz, 1H), 7.02 (t, J = 7.65Hz, 1H), 6.91-6.84 (m, 1H); 
13
C NMR : 168.1, 
167.0, 152.3, 150.2, 150.1, 149.7, 143.2, 141.1, 137.8, 136.3, 132.7, 132.0, 130.6, 129.9, 129.5, 
129.4, 128.8, 124.4, 123.6, 123.1, 122.2, 121.3, 121.2, 120.6, 120.2, 110.3, 109.5 ppm; MS 
(m/z): 222 (M
+
, 100%). (This is a known compound as referenced in literature above, however 
there were no physical properties reported). 
 (Z)-3-(2,6-Dichlorobenzylidene)indolin-2-one (107) 
To a vial was added oxindole (1.877 mmol, 0.2500 g) with 2,6-dichlorobenzaldehyde (1.2 
equivalents, 2.253 mmol, 0.3943 g) piperidine (0.1 equivalents, 0.2253 mmol, 0.0192 g, 0.0223 
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mL) and EtOH (8 mL). The vial was placed on a hot plate at 90˚C for 3 h while stirring. A brown 
precipitate was collected by vacuum filtration and was recrystallized from DCM/hexanes to give 
a brown solid (0.3114 g, 57%) was collected by vacuum filtration: mp 182-184˚C, (lit.
76
mp 179-
181ºC); Rf = 0.45 (EtOAc/hexanes, 1:1);
 1
H NMR (300 MHz, CDCl3) 9.30 (s, N-H), 7.66 (s, 
Hvinyl), 7.46 (d, J = 7.89Hz, 1H), 7.41-7.31 (m, 2H), 7.24 (t, J = 7.43Hz, 1H), 6.96 (d, J =7.62Hz, 
1H), 6.85 (t, J = 7.59Hz, 1H), 6.72 (d, J = 7.59Hz, 1H); 
13
C NMR : 169.4, 141.9, 134.5, 133.0, 
131.8, 130.5, 130.2, 129.7, 128.3, 123.8, 122.3, 121.6, 110.3 ppm; MS (m/z): 289 (M
+
), 254 
(100%). 
(Z)-3-(3,5-Difluorobenzylidene)indolin-2-one (108) 
To a vial was added oxindole (3.75 mmol, 0.4990 g) with 3,5-difluorobenzaldehyde (1.2 
equivalents, 4.56 mmol, 0.6480 g) piperidine (0.1 equivalents, 0.456 mmol, 0.0388 g, 0.0451 
mL) and EtOH (4 mL). The vial was placed on a hot plate at 90˚C for 3 h while stirring. A 
yellow precipitate was collected by vacuum filtration and then recrystallized from ethanol to give 
a yellow/orange solid (0.5716 g, 58%): mp 206-210˚C, (lit.
77
mp 202-205ºC); Rf  = 0.43 
(EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, DMSO-d6)  (s, N-H), 7.56 (s, Hvinyl), 7.41 (d, 
J = 7.05Hz, 1H), 7.42-7.32 (m, 2H), 7.26 (t, J = 7.70Hz, 1H), 6.88 (t, J = 7.7Hz, 1H); 
13
C NMR 
: 167.5, 161.3, 158.0, 143.2, 132.7, 132.0, 130.8, 123.1, 121.5, 120.7, 119.7, 112.1, 110.1 ppm; 
MS (m/z): 257 (M
+
, 100%). 
 (E)-3-(2-Hydroxybenzylidene)indolin-2-one (109) 
To a vial was added oxindole (1.877 mmol, 0.2500 g) with salicyladehyde (1.2 equivalents, 
2.253 mmol, 0.2751 g, 0.2401 mL), piperidine (0.1 equivalents, 0.2253 mmol, 0.0192 g, 0.0223 
mL) and EtOH (8 mL). The vial was placed on a hot plate at 90˚C for 3 h while stirring. A 
 
95 
 
yellow precipitate (0.1965 g, 44%) was collected by vacuum filtration: mp 193-195˚C; (lit.
74
mp 
195-196ºC);
 
Rf = 0.25 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, DMSO-d6) 10.56 (s, N-H), 
10.17 (s, O-H), 7.72 (s, Hvinyl), 7.64 (d, J = 7.56Hz, 1H), 7.51 (d, J = 7.56Hz, 1H), 7.32 (t, J = 
7.77Hz, 1H), 7.22 (t, J = 7.68Hz, 1H), 7.00 (d, J = 8.02Hz, 1H), 6.93 (t, J = 7.37, 1H), 6.89-6.83 
(m, 2H); 
13
C NMR δ: 168.8, 156.4, 142.6, 132.4, 131.5, 129.6, 129.5, 126.5, 122.3, 121.3, 121.3, 
120.9, 118.7, 116.0, 109.9 ppm; MS (m/z): 237 (M
+
, 100%). 
(Z)-3-Benzylidene-2-one (110) 
To a vial was added oxindole (3.77 mmol, 0.5022 g) with benzaldehyde (1.2 equivalents, 4.52 
mmol, 0.4803 g, 0.460 mL), piperidine (0.1 equivalents, 0.4526 mmol, 0.0385 g, 0.0448 mL) and 
EtOH (8 mL). The vial was placed on a hot plate at 90ºC for 3.5h while stirring. A yellow 
precipitate (0.5518g, 66%) was collected by vacuum filtration: mp 172-175ºC; (lit.
79
mp 180-
181ºC); Rf = 0.46 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, CDCl3) 9.30 (s, N-H), 7.88 (s, 
1H), 7.69 (d, J = 7.2Hz, 1H), 7.64 (s, Hvinyl), 7.53-7.45 (m, 5H), 7.24 (t, J = 7.67Hz, 1H), 6.97 (d, 
J = 7.71Hz, 1H), 6.89 (t, J = 7.64Hz, 1H); 
13
C NMR (300 MHz, DMSO-d6) 168.6, 143.0, 135.7, 
134.5, 130.1, 129.6, 129.2, 128.7, 127.7, 122.3, 121.1, 120.9, 110.1 ppm; MS (m/z): 221 (M
+
, 
100%). 
(E)- 3-(2,6-Difluorobenzylidene)-1-benzylindolin-2-one (111) 
To a solution of Z-3-(2,6-difluorobenzylidene)indolin-2-one (1.579 mmol, 0.4062 g) in 
acetonitrile (30 mL), was added KF/alumina (39.2 mmol, 6.00 g) and the resulting mixture was 
allowed to stir for 10 minutes and formed an orange color. Benzyl chloride (1.5 equivalents, 
2.368 mmol, 0.273mL) was added to the round bottom flask dropwise and then refluxed under 
acetonitrile for 12 h. The mixture was then allowed to cool to rt and the suspended KF/alumina 
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was vacuum filtered from the solution. The filtrate was then evaporated under the reduced 
pressure to afford a orange oil, upon which after the addition of a small amount of methanol to 
afforded the pure (TLC, GC/MS) product as orange crystals (0.2130 g, 39%): mp 94-99˚C; Rf = 
0.58 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, CDCl3) (s, Hvinyl), 7.49-7.28 (m, 1H), 
7.19 (td, J = 7.74Hz, 1.08Hz, 1H), 7.11 (d, J = 7.47Hz, 1H), 7.06 (t, J = 7.95Hz, 1H), 6.90 (td, J 
= 7.65Hz, 0.96Hz, 1H), 6.74 (d, J = 7.86Hz, 1H), 5.02 (s, 2H); 
13
C NMR δ: 167.6, 162.2, 158.9, 
143.7, 135.9, 131.4, 131.1, 130.3, 128.8, 127.6, 127.4, 123.7, 122.2, 121.7, 121.2, 113.0, 111.8, 
109.1, 43.9 ppm; MS (m/z): 347 (M
+
, 100%); Anal. Calcd for C22H15F2NO:  C, 76.07; H, 4.35; 
N, 4.03 Found: C, 76.05; H, 4.49; N, 4.05. 
(E)-1-(2,6-Difluorobenzyl)-3-(4-methoxybenzylidene)indolin-2-one (112) 
To a vial was added 1-(2,6-difluorobenzyl)indolin-2-one (1.16 mmol, 0.300 g) with p-
anisaldehyde (1.2 equivalents, 1.39 mmol, 0.1891 g, 0.1689 mL), piperidine (0.2 equivalents, 
0.278 mmol, 0.0236 g, 0.0275 mL) and EtOH (8 mL). The vial was placed on a hot plate at 90˚C 
for 50 h while stirring. A yellow precipitate (0.1225 g, 28%) was collected by vacuum filtration: 
mp 142-143˚C; Rf = 0.66 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, CDCl3)  (s, Hvinyl), 
7.76 (d, J = 7.8Hz, 1H), 7.67 (d, J = 8.58Hz, 1H), 7.31-7.17 (m, Ar-H), 7.00 (d, J = 8.79Hz, 1H),  
6.94-6.87 (m, Ar-H), 5.12 (s, 2H); 
13
C NMR δ: 168.3, 163.4, 160.9, 160.1, 142.7, 137.8, 134.5, 
131.4, 129.8, 129.3, 127.3, 125.0, 122.4, 121.7, 114.1, 111.6, 108.5, 55.4, 32.1 ppm; MS (m/z): 
377 (M
+
, 100%); Anal. Calcd for C23H17F2NO2:  C, 73.20; H, 4.54; N, 3.71 Found: C, 73.23; H, 
4.65; N, 3.74. 
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(E)-1-(2,6-Difluorobenzyl)-3-((pyridin-4-yl)methylene)indolin-2-one (113) 
To a vial was added 1-(2,6-difluorobenzyl)indolin-2-one (1.16 mmol, 0.300 g) with 4-
pyridincarboxaldehyde (1.2 equivalents, 1.39 mmol, 0.1487 g, 0.1308 mL), piperidine (0.1 
equivalents, 0.1390 mmol, 0.0118 g, 0.0137 mL) and EtOH (6 mL). The vial was placed on a hot 
plate at 90˚C for 20 h while stirring. A light-green precipitate (0.2121 g, 53%) was collected by 
vacuum filtration: mp 180-181˚C; Rf = 0.08 (EtOAc/hexanes, 1:1); 
1
H NMR (300 MHz, CDCl3) 
d, J = 6.03Hz, 1H), 7.76 (s, Hvinyl), 7.49 (d, J = 5.34Hz, 1H), 7.42 (d, J = 7.29Hz, 1H), 
7.31-7.20 (m, Ar-H),  6.95-6.86 (m, Ar-H), 5.09 (s, 2H); 
13
C NMR δ: 167.2, 163.3, 160.0, 150.3, 
143.5, 143.2, 133.1, 130.8, 130.0, 129.7, 123.2, 123.0, 122.1, 120.5, 111.7, 111.3, 108.9, 32.2 
ppm; MS (m/z): 348 (M
+
), 127 (100%); Anal. Calcd for C21H14F2N2O:  C, 72.41; H, 4.05; N, 
8.04 Found: C, 72.46; H, 4.10; N, 7.99. 
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